RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Respiratory Tract Infections |
|
Accession: | DOID:9008680
|
browse the term
|
Definition: | Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. |
Synonyms: | exact_synonym: | Respiratory Infection, Upper; Respiratory Infections; Respiratory Tract Infection; Upper Respiratory Infections; Upper Respiratory Tract Infections |
| primary_id: | MESH:D012141; RDO:0000329 |
|
|
GViewer not supported for the selected species.
|
|
G |
BDNF |
brain derived neurotrophic factor |
|
ISO |
protein:decreased expression:platelet, serum |
RGD |
PMID:17317133 |
RGD:4891069 |
NCBI chr 1:37,386,825...37,451,380
Ensembl chr 1:37,449,593...37,450,336
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:19039768 |
RGD:4892119 |
NCBI chr X:61,430,723...61,433,777
Ensembl chr X:61,430,725...61,433,386
|
|
G |
FBLN5 |
fibulin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12189163 |
|
NCBI chr24:69,626,498...69,703,146
Ensembl chr24:69,626,339...69,703,108
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
Severe Acute Respiratory Syndrome |
RGD |
PMID:14633438 |
RGD:4145665 |
NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
|
|
G |
IL16 |
interleukin 16 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:14633438 |
RGD:4145665 |
NCBI chr26:2,080,985...2,208,764
Ensembl chr26:2,077,228...2,208,431
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
associated with Asthma |
RGD |
PMID:20573437 |
RGD:5128554 |
NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
|
|
G |
IL6R |
interleukin 6 receptor |
|
ISO |
DNA:polymorphisms:promoter, exon:-183G>A (human) |
RGD |
PMID:20951753 |
RGD:5128631 |
NCBI chr20:9,345,723...9,418,963
Ensembl chr20:9,361,152...9,396,610
|
|
G |
IRF1 |
interferon regulatory factor 1 |
|
ISO |
|
RGD |
PMID:10497103 |
RGD:5128721 |
NCBI chr23:35,309,058...35,317,765
Ensembl chr23:35,307,772...35,316,763
|
|
G |
IRF3 |
interferon regulatory factor 3 |
|
ISO |
|
RGD |
PMID:17027894 |
RGD:5128795 |
NCBI chr 6:42,835,285...42,841,487
Ensembl chr 6:42,831,203...42,840,796
|
|
G |
LEPR |
leptin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17229951 |
|
NCBI chr20:67,454,205...67,567,524
Ensembl chr20:67,454,334...67,524,229
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
protein:decreased secretion:serum (human) DNA:polymorphisms:5' utr, exon:multiple (human) DNA:SNP:exon:p.G54D(rs1800450)(human) |
RGD |
PMID:15249448 PMID:19169708 PMID:19767106 |
RGD:4889439 RGD:4889453 RGD:8693755 |
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
|
|
G |
MX1 |
MX dynamin like GTPase 1 |
|
ISO |
protein:increased expression:blood (human) |
RGD |
PMID:25542463 |
RGD:126777677 |
NCBI chr 2:85,333,327...85,368,179
Ensembl chr 2:85,338,530...85,368,507
|
|
G |
RPGR |
retinitis pigmentosa GTPase regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12920075 |
|
NCBI chr 9:30,008,681...30,033,475
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
Severe Acute Respiratory Syndrome; protein:increased expression:serum |
RGD |
PMID:14633438 |
RGD:4145665 |
|
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
|
ISO |
associated with Cystic Fibrosis |
RGD |
PMID:17898016 |
RGD:4145612 |
NCBI chr 5:43,343,525...43,350,096
Ensembl chr 5:43,346,329...43,348,599
|
|
G |
CCR1 |
C-C motif chemokine receptor 1 |
|
ISO |
|
RGD |
PMID:15951834 |
RGD:5688155 |
NCBI chr22:7,634,205...7,641,380
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:10946288 |
RGD:8661731 |
NCBI chr22:7,795,192...7,801,242
Ensembl chr22:7,798,646...7,799,728
|
|
G |
CFTR |
CF transmembrane conductance regulator |
|
ISO |
DNA:mutations: : |
RGD |
PMID:11243954 |
RGD:4140482 |
NCBI chr21:86,154,313...86,332,436
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:7743671 |
RGD:8547590 |
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
|
RGD |
PMID:8699818 |
RGD:7794730 |
NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
Chronic Necrotizing Pulmonary Aspergillosis; DNA:missense mutation:exon:p.R52C (human) DNA:SNP:intron:1011G>A(human) |
RGD |
PMID:11474427 PMID:16487239 |
RGD:4889577 RGD:8693711 |
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
|
RGD |
PMID:8699818 |
RGD:7794730 |
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
susceptibility |
ISO |
DNA:snps:5' utr, exon:g.-609G>T rs4149570, g.36A>G rs767455 (human) |
RGD |
PMID:20646338 |
RGD:5131174 |
NCBI chr11:6,364,544...6,378,880
Ensembl chr11:6,364,330...6,378,902
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
severity |
ISO |
DNA:snp:exon:c.1236C>T (human) |
RGD |
PMID:24040855 |
RGD:8657076 |
NCBI chr21:61,211,044...61,430,691
Ensembl chr21:61,322,748...61,529,274
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
|
ISO |
mRNA, protein:increased expression:nasal mucosa (rat) |
RGD |
PMID:15362690 |
RGD:11522724 |
NCBI chr18:16,440,560...16,643,187
Ensembl chr18:16,441,733...16,637,895
|
|
G |
CAT |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29028686 |
|
NCBI chr 1:30,792,533...30,828,920
Ensembl chr 1:30,792,399...30,829,592
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
treatment |
ISO |
|
RGD |
PMID:23089405 |
RGD:7248414 |
NCBI chr16:27,792,699...27,796,437
Ensembl chr16:27,794,033...27,796,460
|
|
G |
CCL26 |
C-C motif chemokine ligand 26 |
|
ISO |
protein:increased expression:oronasal secretion (human) |
RGD |
PMID:23883806 |
RGD:7364793 |
NCBI chr28:10,036,177...10,038,962
Ensembl chr28:10,036,337...10,038,875
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
protein:increased expression:lymphocyte |
RGD |
PMID:19086656 |
RGD:8547782 |
NCBI chr 2:17,753,713...17,765,134
Ensembl chr 2:17,753,394...17,764,566
|
|
G |
CD40LG |
CD40 ligand |
|
ISO |
protein:increased expression:lymphocyte |
RGD |
PMID:19086656 |
RGD:8547782 |
NCBI chr X:111,655,301...111,667,602
Ensembl chr X:111,655,397...111,666,639
|
|
G |
CLDN3 |
claudin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
NCBI chr28:9,301,312...9,303,496
Ensembl chr28:9,302,446...9,303,108
|
|
G |
CLDN7 |
claudin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
NCBI chr16:6,632,695...6,635,994
Ensembl chr16:6,630,412...6,635,327
|
|
G |
CTLA4 |
cytotoxic T-lymphocyte associated protein 4 |
treatment |
ISO |
|
RGD |
PMID:10436391 |
RGD:11344920 |
NCBI chr10:89,637,176...89,644,436
Ensembl chr10:89,638,314...89,642,344
|
|
G |
FCGR3A |
Fc fragment of IgG receptor IIIa |
susceptibility |
ISO |
DNA:polymorphism:exon:p.F158V(rs396991)(human) |
RGD |
PMID:18199088 |
RGD:5508449 |
NCBI chr20:2,466,492...2,475,579
|
|
G |
GRIA1 |
glutamate ionotropic receptor AMPA type subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34624383 |
|
NCBI chr23:55,944,128...56,265,748
Ensembl chr23:56,101,294...56,265,849
|
|
G |
GRIA2 |
glutamate ionotropic receptor AMPA type subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34624383 |
|
NCBI chr 7:103,808,789...103,957,947
Ensembl chr 7:103,808,797...103,953,040
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36127783 |
|
NCBI chr19:18,144,466...18,157,944
Ensembl chr19:18,144,545...18,157,971
|
|
G |
HRH1 |
histamine receptor H1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23333628 |
|
NCBI chr22:47,187,156...47,298,761
Ensembl chr22:47,295,011...47,296,471
|
|
G |
IFNG |
interferon gamma |
treatment |
ISO |
associated with Asthma CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:12787306 PMID:18510219 PMID:29871060 |
RGD:10755770 RGD:7829803 |
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
|
|
G |
IL10 |
interleukin 10 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:23253209 PMID:23883806 PMID:36127783 |
RGD:7364793 RGD:7364818 |
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
|
|
G |
IL13 |
interleukin 13 |
susceptibility no_association |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNPs:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human) |
OMIM CTD RGD |
PMID:12928861 |
RGD:8549516 |
NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
|
|
G |
IL13RA2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21462799 |
RGD:8549521 |
NCBI chr X:102,589,947...102,628,853
Ensembl chr X:102,590,045...102,603,260
|
|
G |
IL17A |
interleukin 17A |
susceptibility |
ISO |
mRNA:increased expression:peripheral blood mononuclear cell (human) DNA:snp:promoter:c.-444A>G (human) |
RGD |
PMID:21535180 PMID:22507625 |
RGD:5147409 RGD:9068429 |
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
|
|
G |
IL18 |
interleukin 18 |
no_association severity |
ISO |
DNA:SNP:promoter:-140C>G (rs360721) (human) DNA:SNP:promoter:-137G>C (rs187238) (human) |
RGD |
PMID:22840759 |
RGD:8655914 |
NCBI chr 1:103,485,868...103,511,632
Ensembl chr 1:103,482,083...103,510,150
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:7750009 |
RGD:7401199 |
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
|
|
G |
IL2 |
interleukin 2 |
|
ISO |
|
RGD |
PMID:12592663 |
RGD:8662963 |
NCBI chr 7:69,729,635...69,736,279
Ensembl chr 7:69,730,282...69,734,969
|
|
G |
IL4 |
interleukin 4 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:8908280 PMID:9893928 PMID:14653048 PMID:24620662 PMID:36127783 |
RGD:11522769 RGD:7829796 RGD:7829802 RGD:7829827 |
NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
|
|
G |
IL5 |
interleukin 5 |
treatment |
ISO |
|
RGD |
PMID:23934070 PMID:24620662 |
RGD:11354976 RGD:11522769 |
NCBI chr23:35,360,143...35,375,169
Ensembl chr23:35,360,506...35,362,178
|
|
G |
ITGB2 |
integrin subunit beta 2 |
treatment |
ISO |
|
RGD |
PMID:12046991 |
RGD:9698435 |
NCBI chr 2:88,597,554...88,644,890
Ensembl chr 2:88,597,556...88,624,025
|
|
G |
MRC1 |
mannose receptor C-type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36127783 |
|
NCBI chr 9:17,751,053...17,849,258
Ensembl chr 9:17,751,133...17,849,406
|
|
G |
MUC1 |
mucin 1, cell surface associated |
severity |
ISO |
mRNA,protein:decreased expression:nasal mucosa |
RGD |
PMID:31425778 |
RGD:127345100 |
NCBI chr20:8,641,701...8,646,739
Ensembl chr20:8,642,842...8,646,962
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
mRNA, protein:increased expression:nasal cavity epithelium |
RGD |
PMID:22972875 |
RGD:7364746 |
NCBI chr 1:981,515...1,018,242
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
mRNA:increased expression:nasal mucosa (human) |
RGD |
PMID:23858718 |
RGD:8547523 |
NCBI chr 5:36,492,158...36,531,766
Ensembl chr 5:36,496,414...36,530,499
|
|
G |
OCLN |
occludin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
NCBI chr 4:65,581,943...65,641,516
Ensembl chr 4:65,582,460...65,644,787
|
|
G |
PON1 |
paraoxonase 1 |
severity |
ISO |
protein:decreased activity:plasma (human) |
RGD |
PMID:23406590 |
RGD:8547583 |
NCBI chr21:53,713,434...53,739,658
Ensembl chr21:53,714,012...53,739,875
|
|
G |
PRKG1 |
protein kinase cGMP-dependent 1 |
|
ISO |
protein:increased expression:nasal cavity epithelium |
RGD |
PMID:24012634 |
RGD:7775060 |
NCBI chr 9:78,858,269...80,188,163
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16979129 |
|
NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
|
|
G |
SCGB1A1 |
secretoglobin family 1A member 1 |
|
ISO |
mRNA:decreased expression:nasal mucosa, lung |
RGD |
PMID:17882576 |
RGD:5144135 |
NCBI chr 1:11,470,091...11,474,915
Ensembl chr 1:11,470,195...11,474,149
|
|
G |
SCGB3A2 |
secretoglobin family 3A member 2 |
susceptibility |
ISO |
DNA:SNP: :rs7726552 (human) |
RGD |
PMID:21410962 |
RGD:5144225 |
NCBI chr23:50,327,428...50,417,518
Ensembl chr23:50,414,139...50,417,373
|
|
G |
SERPINE1 |
serpin family E member 1 |
|
ISO |
mRNA:increased expression:nasal mucosa (mouse) |
RGD |
PMID:21339035 |
RGD:8547809 |
NCBI chr28:12,047,520...12,060,662
Ensembl chr28:12,047,529...12,060,202
|
|
G |
TACR1 |
tachykinin receptor 1 |
|
ISO |
mRNA:increased expression:nasal mucosa |
RGD |
PMID:12768696 |
RGD:5147835 |
NCBI chr14:32,080,319...32,236,556
Ensembl chr14:32,083,615...32,233,596
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
treatment |
ISO |
|
RGD |
PMID:31368266 |
RGD:14995445 |
NCBI chr 6:35,651,583...35,674,387
Ensembl chr 6:35,648,677...35,674,365
|
|
G |
TLR2 |
toll like receptor 2 |
severity |
ISO |
DNA:polymorphism:cds:p.R753Q(human) protein:increased expression:neutrophil: mRNA:decreased expression:nasal mucosa: |
RGD |
PMID:18219831 PMID:18381801 PMID:22402138 PMID:22555057 |
RGD:7800732 RGD:7800742 RGD:8552972 RGD:8552993 |
NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
|
|
G |
TLR4 |
toll like receptor 4 |
severity susceptibility no_association treatment |
ISO |
DNA:polymorphism:cds:p.D299G(human) DNA:SNP: :rs1927911(human) protein:decreased expression:nasal mucosa: DNA:polymorphism: :4216G>C(human) protein:increased expression:nasal lavage,leukocyte, bone marrow: |
RGD |
PMID:17069098 PMID:19763595 PMID:22402138 PMID:22555057 PMID:22577387 PMID:23639307 More...
|
RGD:4145354 RGD:7800732 RGD:7800736 RGD:7800738 RGD:7800740 RGD:8552993 |
NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
|
|
|
G |
CYP2C19 |
cytochrome P450 family 2 subfamily C member 19 |
treatment |
ISO |
associated with Eosinophilic Esophagitis; DNA:polymorphisms:: |
RGD |
PMID:26416193 |
RGD:11352743 |
NCBI chr 9:87,981,300...88,025,007
|
|
G |
IL3 |
interleukin 3 |
susceptibility |
ISO |
DNA:SNP: :rs40401(human) |
RGD |
PMID:23953855 |
RGD:13506915 |
NCBI chr23:34,894,630...34,899,105
|
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
|
ISO |
DNA:SNP:promoter:-374T>A (human) |
RGD |
PMID:22114731 |
RGD:8695981 |
NCBI chr17:39,847,343...39,851,288
Ensembl chr17:39,847,759...39,851,127
|
|
G |
CCL19 |
C-C motif chemokine ligand 19 |
|
ISO |
associated with Neutropenia;mRNA:increased expression:lung |
RGD |
PMID:19783686 |
RGD:5130908 |
NCBI chr12:45,928,212...45,930,897
Ensembl chr12:45,929,071...45,930,904
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
|
ISO |
associated with Neutropenia |
RGD |
PMID:19783686 |
RGD:5130908 |
NCBI chr16:65,620,632...65,632,394
Ensembl chr16:65,620,665...65,632,984
|
|
G |
CD209 |
CD209 molecule |
|
ISO |
|
RGD |
PMID:21381282 |
RGD:5131183 |
NCBI chr 6:7,219,576...7,235,755
Ensembl chr 6:7,228,378...7,235,208
|
|
G |
CFTR |
CF transmembrane conductance regulator |
severity |
ISO |
|
RGD |
PMID:22135344 |
RGD:35673332 |
NCBI chr21:86,154,313...86,332,436
|
|
G |
CLEC1A |
C-type lectin domain family 1 member A |
susceptibility |
ISO |
ClinVar Annotator: match by term: Aspergillosis, susceptibility to |
OMIM ClinVar |
PMID:25741868 PMID:29489751 |
|
NCBI chr11:9,945,978...9,989,506
Ensembl chr11:9,945,645...9,973,741
|
|
G |
CLEC7A |
C-type lectin domain containing 7A |
susceptibility |
ISO |
ClinVar Annotator: match by term: CLEC7A-related condition |
ClinVar OMIM |
PMID:19864674 PMID:20807886 PMID:24033266 PMID:25741868 PMID:28492532 |
|
NCBI chr11:9,989,520...10,007,442
Ensembl chr11:9,995,203...10,006,746
|
|
G |
CRP |
C-reactive protein |
treatment |
ISO |
|
RGD |
PMID:20879853 |
RGD:9495929 |
NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:16893395 |
RGD:4981337 |
NCBI chr 7:88,548,773...88,644,977
Ensembl chr 7:88,548,671...88,645,488
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
|
RGD |
PMID:20064561 |
RGD:8694071 |
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
|
|
G |
S100B |
S100 calcium binding protein B |
|
ISO |
DNA:SNP: :427C>T (human) |
RGD |
PMID:22114731 |
RGD:8695981 |
NCBI chr 2:90,188,820...90,194,986
Ensembl chr 2:90,188,639...90,195,023
|
|
G |
TLR1 |
toll like receptor 1 |
susceptibility |
ISO |
DNA:SNPs: :p.R80T, p.N248S (human) |
RGD |
PMID:16461792 |
RGD:4889535 |
NCBI chr27:11,482,307...11,490,847
Ensembl chr27:11,488,294...11,490,654
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19781388 |
RGD:4145322 |
NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
|
|
G |
TLR6 |
toll like receptor 6 |
susceptibility |
ISO |
DNA:SNP: :p.S249P (human) |
RGD |
PMID:16461792 |
RGD:4889535 |
NCBI chr27:11,439,288...11,461,580
Ensembl chr27:11,459,181...11,461,571
|
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:19515386 |
RGD:4891456 |
NCBI chr 7:22,327,041...22,329,405
Ensembl chr 7:22,569,355...22,569,900 Ensembl chr 7:22,569,355...22,569,900
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
protein:increased secretion:plasma (rat) |
RGD |
PMID:19262391 |
RGD:4145069 |
NCBI chr17:59,854,186...59,861,319
Ensembl chr17:59,853,699...59,861,198
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
protein:increased expression:Bronchoalveolar Lavage Fluid |
RGD |
PMID:18042282 |
RGD:4142854 |
NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15607125 |
|
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
protein:increased expression:Bronchoalveolar Lavage Fluid |
RGD |
PMID:18042282 |
RGD:4142854 |
|
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
severity |
ISO |
protein:increased expression:nasal mucus (human) |
RGD |
PMID:24211414 |
RGD:40925940 |
NCBI chr 7:22,202,497...22,205,730
Ensembl chr 7:22,202,527...22,204,068
|
|
G |
MARCO |
macrophage receptor with collagenous structure |
disease_progression |
ISO |
association with Cryptococcal neoformans infection. |
RGD |
PMID:28298522 |
RGD:41412191 |
NCBI chr10:11,329,036...11,389,428
Ensembl chr10:11,329,026...11,388,999
|
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
|
ISO |
|
RGD |
PMID:11238654 |
RGD:5128828 |
NCBI chr 5:14,972,589...15,164,594
Ensembl chr 5:14,972,646...15,164,567
|
|
G |
ACE2 |
angiotensin converting enzyme 2 |
|
ISO |
associated with Pseudomonas Infections;mRNA, protein:altered expression, altered activity:lung (mouse) |
RGD |
PMID:31645418 |
RGD:40818279 |
NCBI chr X:14,032,231...14,094,163
Ensembl chr X:14,030,233...14,077,785
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
severity |
ISO |
|
RGD |
PMID:21629785 |
RGD:6767559 |
NCBI chr17:39,847,343...39,851,288
Ensembl chr17:39,847,759...39,851,127
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:16014897 |
RGD:5129508 |
NCBI chr 6:6,250,422...6,289,264
|
|
G |
C3AR1 |
complement C3a receptor 1 |
|
ISO |
|
RGD |
PMID:16461429 |
RGD:5129690 |
NCBI chr11:8,128,192...8,135,517
Ensembl chr11:8,128,620...8,130,062
|
|
G |
C5 |
complement C5 |
|
ISO |
|
RGD |
PMID:17975174 |
RGD:5129707 |
NCBI chr12:18,525,855...18,624,048
Ensembl chr12:18,525,880...18,623,636
|
|
G |
CAT |
catalase |
|
ISO |
protein:decreased expression:lung, plasma |
RGD |
PMID:19842849 |
RGD:5130748 |
NCBI chr 1:30,792,533...30,828,920
Ensembl chr 1:30,792,399...30,829,592
|
|
G |
CCL19 |
C-C motif chemokine ligand 19 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:20176793 |
RGD:5130918 |
NCBI chr12:45,928,212...45,930,897
Ensembl chr12:45,929,071...45,930,904
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
|
RGD |
PMID:20042590 |
RGD:4891443 |
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:20042590 |
RGD:4891443 |
NCBI chr22:7,795,192...7,801,242
Ensembl chr22:7,798,646...7,799,728
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
|
ISO |
|
RGD |
PMID:20176793 |
RGD:5130918 |
NCBI chr16:65,620,632...65,632,394
Ensembl chr16:65,620,665...65,632,984
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:16210672 |
RGD:4144197 |
NCBI chr23:43,264,917...43,266,825
Ensembl chr23:43,264,336...43,266,993
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20102413 |
RGD:5132268 |
NCBI chr 2:17,753,713...17,765,134
Ensembl chr 2:17,753,394...17,764,566
|
|
G |
CD80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:20949109 |
RGD:4892562 |
NCBI chr22:61,258,281...61,294,772
|
|
G |
CHUK |
component of inhibitor of nuclear factor kappa B kinase complex |
|
ISO |
|
RGD |
PMID:18643924 |
RGD:5133701 |
NCBI chr 9:93,219,374...93,263,077
Ensembl chr 9:93,219,383...93,262,700
|
|
G |
CSF3 |
colony stimulating factor 3 |
disease_progression treatment |
ISO |
associated with Peritonitis; |
RGD |
PMID:12352049 PMID:21373266 |
RGD:11039437 RGD:5133733 |
NCBI chr16:66,162,814...66,166,192
Ensembl chr16:66,163,681...66,165,172
|
|
G |
CSF3R |
colony stimulating factor 3 receptor |
disease_progression |
ISO |
|
RGD |
PMID:17185469 |
RGD:5133739 |
NCBI chr20:96,380,798...96,397,745
Ensembl chr20:96,384,222...96,398,618
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:11052817 PMID:21723409 |
RGD:5135062 RGD:5135234 |
NCBI chr 7:22,327,041...22,329,405
Ensembl chr 7:22,569,355...22,569,900 Ensembl chr 7:22,569,355...22,569,900
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
severity |
ISO |
|
RGD |
PMID:15618188 PMID:16299319 |
RGD:5135458 RGD:5135459 |
NCBI chr 7:24,526,657...24,529,193
Ensembl chr 7:24,526,680...24,529,130
|
|
G |
CXCL11 |
C-X-C motif chemokine ligand 11 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr 7:24,540,401...24,543,456
Ensembl chr 7:24,541,767...24,542,832
|
|
G |
CXCL6 |
C-X-C motif chemokine ligand 6 |
|
ISO |
|
RGD |
PMID:19846873 |
RGD:4145490 |
NCBI chr 7:22,291,949...22,294,191
Ensembl chr 7:22,292,045...22,294,207
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr 7:24,507,121...24,513,830
Ensembl chr 7:24,507,130...24,513,121
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr X:61,430,723...61,433,777
Ensembl chr X:61,430,725...61,433,386
|
|
G |
CYP2J2 |
cytochrome P450 family 2 subfamily J member 2 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:14766666 |
RGD:1625385 |
NCBI chr20:73,083,312...73,115,174
Ensembl chr20:73,083,389...73,115,077
|
|
G |
FOXP3 |
forkhead box P3 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr X:46,349,890...46,365,133
|
|
G |
GP1BA |
glycoprotein Ib platelet subunit alpha |
exacerbates |
ISO |
associated with Escherichia Coli Infections |
RGD |
PMID:27845343 |
RGD:42722624 |
NCBI chr16:4,412,693...4,415,841
|
|
G |
GRK2 |
G protein-coupled receptor kinase 2 |
|
ISO |
mRNA:decreased expression:polymorphonuclear leukocyte |
RGD |
PMID:24465168 |
RGD:126848796 |
NCBI chr 1:6,975,202...6,995,369
Ensembl chr 1:6,975,002...6,995,259
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:lung (mouse) |
RGD |
PMID:19846873 |
RGD:4145490 |
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
|
|
G |
IFNAR1 |
interferon alpha and beta receptor subunit 1 |
severity |
ISO |
|
RGD |
PMID:19487810 |
RGD:5490274 |
NCBI chr 2:58,824,600...58,854,519
Ensembl chr 2:58,825,916...58,854,568
|
|
G |
IFNG |
interferon gamma |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
|
|
G |
IL10 |
interleukin 10 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
|
RGD |
PMID:17911627 |
RGD:5000754 |
NCBI chr 7:88,548,773...88,644,977
Ensembl chr 7:88,548,671...88,645,488
|
|
G |
IL17A |
interleukin 17A |
severity |
ISO |
|
RGD |
PMID:18802100 PMID:25398094 |
RGD:38501102 RGD:4889153 |
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:17664259 |
RGD:4889913 |
NCBI chr 1:103,485,868...103,511,632
Ensembl chr 1:103,482,083...103,510,150
|
|
G |
IL1B |
interleukin 1 beta |
treatment severity |
ISO |
associated with Agranulocytosis |
RGD |
PMID:7546648 PMID:18596024 PMID:25398094 |
RGD:10755357 RGD:38501102 RGD:4143205 |
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
|
|
G |
IL1RL1 |
interleukin 1 receptor like 1 |
treatment |
ISO |
associated with Acinetobacter infectious disease associated with Sepsis |
RGD |
PMID:20959556 PMID:29508184 |
RGD:40818077 RGD:5144223 |
NCBI chr14:5,966,551...6,020,391
Ensembl chr14:6,005,061...6,020,265
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
|
RGD |
PMID:18322242 PMID:18596024 |
RGD:4143205 RGD:4143206 |
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
|
|
G |
IL6 |
interleukin 6 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
|
|
G |
IRAK3 |
interleukin 1 receptor associated kinase 3 |
|
ISO |
|
RGD |
PMID:20439918 PMID:28120642 |
RGD:34888234 RGD:36049799 |
NCBI chr11:61,868,817...61,920,896
Ensembl chr11:61,869,173...61,920,406
|
|
G |
IRF1 |
interferon regulatory factor 1 |
|
ISO |
|
RGD |
PMID:11854220 |
RGD:5128725 |
NCBI chr23:35,309,058...35,317,765
Ensembl chr23:35,307,772...35,316,763
|
|
G |
IRF3 |
interferon regulatory factor 3 |
|
ISO |
|
RGD |
PMID:20720199 |
RGD:4891951 |
NCBI chr 6:42,835,285...42,841,487
Ensembl chr 6:42,831,203...42,840,796
|
|
G |
ITGB3 |
integrin subunit beta 3 |
|
ISO |
protein:increased expression:lung, neutrophil |
RGD |
PMID:15114484 |
RGD:4993468 |
NCBI chr16:59,372,171...59,431,434
Ensembl chr16:59,374,889...59,410,857
|
|
G |
LEP |
leptin |
|
ISO |
|
RGD |
PMID:11937559 |
RGD:5128871 |
NCBI chr21:97,056,913...97,071,161
Ensembl chr21:97,057,529...97,071,220
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
severity |
ISO |
associated with Escherichia Coli Infections |
RGD |
PMID:22514650 |
RGD:150340681 |
NCBI chr 9:43,356,603...43,489,066
Ensembl chr 9:43,356,308...43,393,425
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
ISO |
Legionella Pneumonia; DNA:mutations:5' utr, exon:multiple (human) |
RGD |
PMID:18641104 |
RGD:4889477 |
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:bronchoalveolar lavage fluid |
RGD |
PMID:17202364 PMID:19535150 |
RGD:5129533 RGD:5130727 |
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
|
|
G |
MPO |
myeloperoxidase |
|
ISO |
protein:increased activity:bronchoalveolar lavage Fluid: |
RGD |
PMID:11269653 |
RGD:5130992 |
NCBI chr16:35,120,194...35,130,851
Ensembl chr16:35,120,581...35,130,671
|
|
G |
NOD1 |
nucleotide binding oligomerization domain containing 1 |
|
ISO |
|
RGD |
PMID:19360122 |
RGD:5131449 |
NCBI chr21:27,907,628...27,957,621
Ensembl chr21:27,926,710...27,957,619
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:19360122 |
RGD:5131449 |
NCBI chr 5:36,492,158...36,531,766
Ensembl chr 5:36,496,414...36,530,499
|
|
G |
PDPN |
podoplanin |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:7864138 |
RGD:2292375 |
NCBI chr20:118,644,060...118,679,508
Ensembl chr20:118,644,051...118,679,311
|
|
G |
PECAM1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:12524254 |
RGD:724645 |
NCBI chr16:56,863,763...56,947,479
Ensembl chr16:56,880,934...56,950,999
|
|
G |
PGF |
placental growth factor |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:16702604 |
RGD:6483601 |
NCBI chr24:52,160,904...52,174,493
Ensembl chr24:52,161,787...52,173,989
|
|
G |
PTEN |
phosphatase and tensin homolog |
ameliorates |
ISO |
myeloid knockout |
RGD |
PMID:21527775 |
RGD:127285594 |
NCBI chr 9:81,308,058...81,412,386
Ensembl chr 9:81,309,099...81,409,146
|
|
G |
RIPK3 |
receptor interacting serine/threonine kinase 3 |
ameliorates |
ISO |
|
RGD |
PMID:28387756 |
RGD:127229944 |
NCBI chr24:1,318,265...1,322,610
Ensembl chr24:1,318,216...1,322,462
|
|
G |
RORC |
RAR related orphan receptor C |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr20:11,854,911...11,880,221
Ensembl chr20:11,855,005...11,879,717
|
|
G |
SERPINE1 |
serpin family E member 1 |
severity |
ISO |
|
RGD |
PMID:17032919 |
RGD:4144840 |
NCBI chr28:12,047,520...12,060,662
Ensembl chr28:12,047,529...12,060,202
|
|
G |
SFTPB |
surfactant protein B |
|
ISO |
associated with Cystic Fibrosis;protein:increased expression:lung |
RGD |
PMID:12169586 PMID:15271694 |
RGD:4143403 RGD:4143464 |
NCBI chr14:21,487,424...21,497,491
Ensembl chr14:21,488,387...21,499,850
|
|
G |
SFTPC |
surfactant protein C |
|
ISO |
|
RGD |
PMID:12169586 PMID:18566429 |
RGD:4143464 RGD:4144114 |
NCBI chr 8:20,229,756...20,233,568
Ensembl chr 8:20,230,870...20,234,020
|
|
G |
SFTPD |
surfactant protein D |
|
ISO |
associated with Cystic Fibrosis;protein:decreased expression:lung protein:increased expression:lung |
RGD |
PMID:12169586 PMID:15271694 |
RGD:4143403 RGD:4143464 |
NCBI chr 9:51,809,241...51,820,974
Ensembl chr 9:51,811,052...51,820,650
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
|
ISO |
|
RGD |
PMID:18192501 |
RGD:6892945 |
NCBI chr16:63,877,884...63,957,894
Ensembl chr16:63,922,862...63,957,984
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 6:35,651,583...35,674,387
Ensembl chr 6:35,648,677...35,674,365
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:18768871 PMID:19844782 |
RGD:4145337 RGD:4889533 |
NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
|
|
G |
TLR4 |
toll like receptor 4 |
|
ISO |
|
RGD |
PMID:16210672 PMID:20650991 |
RGD:4144172 RGD:4144197 |
NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
|
|
G |
TLR5 |
toll like receptor 5 |
|
ISO |
|
RGD |
PMID:19801452 |
RGD:5129503 |
NCBI chr25:6,418,895...6,440,433
Ensembl chr25:6,437,638...6,440,211
|
|
G |
TLR6 |
toll like receptor 6 |
|
ISO |
|
RGD |
PMID:19844782 |
RGD:4889533 |
NCBI chr27:11,439,288...11,461,580
Ensembl chr27:11,459,181...11,461,571
|
|
G |
TNF |
tumor necrosis factor |
severity treatment disease_progression |
ISO |
associated with Agranulocytosis |
RGD |
PMID:7546648 PMID:9310939 PMID:10650487 PMID:12958055 |
RGD:10449451 RGD:10450564 RGD:10755357 RGD:4143476 |
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:serum (mouse) |
RGD |
PMID:19842848 |
RGD:5131429 |
NCBI chr11:6,364,544...6,378,880
Ensembl chr11:6,364,330...6,378,902
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
|
ISO |
protein:increased expression:serum (mouse) |
RGD |
PMID:19842848 |
RGD:5131429 |
NCBI chr20:119,590,621...119,633,562
Ensembl chr20:119,590,325...119,633,497
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
severity ameliorates |
ISO |
|
RGD |
PMID:16960786 PMID:22996209 PMID:24465168 |
RGD:126848796 RGD:126925987 RGD:127229902 |
NCBI chr17:30,873,647...30,885,292
Ensembl chr17:30,873,666...30,886,967
|
|
G |
ZC3H12A |
zinc finger CCCH-type containing 12A |
|
ISO |
associated with Pseudomonas Infections |
RGD |
PMID:29695841 |
RGD:39938967 |
NCBI chr20:95,388,469...95,398,305
Ensembl chr20:95,388,477...95,397,960
|
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
|
ISO |
|
RGD |
PMID:17687719 |
RGD:4145098 |
NCBI chr23:51,445,920...51,447,942
Ensembl chr23:51,446,154...51,447,401
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
severity |
ISO |
associated with Respiratory Syncytial Virus Infections protein:increased expression:nasal mucus |
RGD |
PMID:15681407 PMID:17297249 |
RGD:4145415 RGD:4145460 |
NCBI chr16:27,792,699...27,796,437
Ensembl chr16:27,794,033...27,796,460
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:19470255 |
RGD:5132271 |
NCBI chr 2:17,753,713...17,765,134
Ensembl chr 2:17,753,394...17,764,566
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
protein:decreased expression:myeloid dendritic cell (mouse) |
RGD |
PMID:20046053 |
RGD:4892291 |
NCBI chr22:58,741,534...58,805,417
Ensembl chr22:58,741,525...58,805,366
|
|
G |
CRP |
C-reactive protein |
severity |
ISO |
|
RGD |
PMID:21284715 |
RGD:5131282 |
NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
|
|
G |
IL17A |
interleukin 17A |
susceptibility |
ISO |
DNA:SNP:promoter:rs2275913 (human) |
RGD |
PMID:20437253 |
RGD:4889139 |
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:8608647 |
RGD:4143192 |
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:8608647 |
RGD:4143192 |
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
|
|
G |
LOC103232241 |
cysteinyl leukotriene receptor 1 |
|
ISO |
associated with Pneumovirus Infections |
RGD |
PMID:16337014 |
RGD:4843953 |
NCBI chr X:67,218,777...67,300,655
Ensembl chr X:67,220,048...67,221,061
|
|
G |
MUC5B |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
DNA:polymorphisms:promoter:rs885454,rs17235353, rs7115457 (human) |
RGD |
PMID:15709052 |
RGD:7349353 |
NCBI chr 1:1,040,756...1,083,246
Ensembl chr 1:1,042,110...1,081,240
|
|
|
G |
ADORA2A |
adenosine A2a receptor |
|
ISO |
|
RGD |
PMID:19766783 |
RGD:4890362 |
NCBI chr19:7,691,678...7,706,781
Ensembl chr19:7,691,536...7,706,926
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
|
ISO |
|
RGD |
PMID:18785972 |
RGD:4145604 |
NCBI chr 5:43,343,525...43,350,096
Ensembl chr 5:43,346,329...43,348,599
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
|
RGD |
PMID:14611812 |
RGD:2307195 |
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
|
|
G |
CCL22 |
C-C motif chemokine ligand 22 |
|
ISO |
|
RGD |
PMID:20628341 |
RGD:4891471 |
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
mRNA:increased expression:lung (rat) |
RGD |
PMID:14611812 PMID:19840961 |
RGD:2307195 RGD:4889978 |
NCBI chr16:29,351,214...29,361,317
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
|
ISO |
protein:increased expression:bronchoalveolar Lavage fluid |
RGD |
PMID:22215510 |
RGD:6483763 |
NCBI chr16:27,777,795...27,780,413
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
mRNA:increased expression:trachea: |
RGD |
PMID:11518728 |
RGD:4145124 |
NCBI chr22:7,795,192...7,801,242
Ensembl chr22:7,798,646...7,799,728
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
|
RGD |
PMID:11266944 |
RGD:2307206 |
NCBI chr22:58,741,534...58,805,417
Ensembl chr22:58,741,525...58,805,366
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO |
associated with Respiratory Aspiration;protein:increased expression:serum |
RGD |
PMID:18557728 |
RGD:2317286 |
NCBI chr23:34,906,987...34,911,252
Ensembl chr23:34,908,911...34,911,140
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12097412 PMID:16709871 |
RGD:5135441 RGD:5135451 |
NCBI chr 7:24,526,657...24,529,193
Ensembl chr 7:24,526,680...24,529,130
|
|
G |
CXCL11 |
C-X-C motif chemokine ligand 11 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12097412 |
RGD:5135451 |
NCBI chr 7:24,540,401...24,543,456
Ensembl chr 7:24,541,767...24,542,832
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12097412 PMID:16709871 |
RGD:5135441 RGD:5135451 |
NCBI chr 7:24,507,121...24,513,830
Ensembl chr 7:24,507,130...24,513,121
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:12097412 PMID:16709871 |
RGD:5135441 RGD:5135451 |
NCBI chr X:61,430,723...61,433,777
Ensembl chr X:61,430,725...61,433,386
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
human gene in a rat model |
RGD |
PMID:9595474 |
RGD:8662402 |
NCBI chr17:59,854,186...59,861,319
Ensembl chr17:59,853,699...59,861,198
|
|
G |
FOXP3 |
forkhead box P3 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19840961 |
RGD:4889978 |
NCBI chr X:46,349,890...46,365,133
|
|
G |
GZMB |
granzyme B |
|
ISO |
|
RGD |
PMID:19737140 |
RGD:5135518 |
NCBI chr24:1,574,452...1,577,861
Ensembl chr24:1,574,453...1,577,798
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
ISO |
|
RGD |
PMID:12973103 |
RGD:4145412 |
NCBI chr19:18,144,466...18,157,944
Ensembl chr19:18,144,545...18,157,971
|
|
G |
IFNG |
interferon gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16137903 |
|
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:bronchoalveolar lavage fluid |
RGD |
PMID:17182591 |
RGD:4146242 |
NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
|
|
G |
IL13RA1 |
interleukin 13 receptor subunit alpha 1 |
|
ISO |
|
RGD |
PMID:17182591 |
RGD:4146242 |
|
|
G |
IL13RA2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
|
RGD |
PMID:17182591 |
RGD:4146242 |
NCBI chr X:102,589,947...102,628,853
Ensembl chr X:102,590,045...102,603,260
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
mRNA:increased expression:trachea |
RGD |
PMID:20393404 |
RGD:4143277 |
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11889437 |
RGD:4143176 |
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:18557728 |
RGD:2317286 |
NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
|
RGD |
PMID:20393404 |
RGD:4143277 |
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
|
|
G |
MBL2 |
mannose binding lectin 2 |
resistance |
ISO |
DNA:transversion:5' utr:-290C>G rs7096206 (human) |
RGD |
PMID:19104434 |
RGD:4889456 |
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression, increased activity:bronchoalveolar lavage fluid |
RGD |
PMID:20417130 |
RGD:5130759 |
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
|
|
G |
MUC1 |
mucin 1, cell surface associated |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:16969297 |
RGD:5131273 |
NCBI chr20:8,641,701...8,646,739
Ensembl chr20:8,642,842...8,646,962
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:18158963 |
RGD:5131450 |
NCBI chr 5:36,492,158...36,531,766
Ensembl chr 5:36,496,414...36,530,499
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
associated with lung transplantation; protein:increased expression:lung |
RGD |
PMID:11112135 |
RGD:4892082 |
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
|
|
G |
NOS3 |
nitric oxide synthase 3 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:15136885 |
RGD:4892068 |
NCBI chr21:119,174,829...119,196,840
|
|
G |
SCGB1A1 |
secretoglobin family 1A member 1 |
|
ISO |
associated with lung transplantation; protein:decreased expression:serum,bronchoalveolar lavage |
RGD |
PMID:11981419 |
RGD:5147386 |
NCBI chr 1:11,470,091...11,474,915
Ensembl chr 1:11,470,195...11,474,149
|
|
G |
SFTPD |
surfactant protein D |
|
ISO |
|
RGD |
PMID:18347569 |
RGD:4143500 |
NCBI chr 9:51,809,241...51,820,974
Ensembl chr 9:51,811,052...51,820,650
|
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:14593914 |
RGD:4889126 |
NCBI chr26:8,753,236...8,759,378
Ensembl chr26:8,753,327...8,759,384
|
|
G |
EGR1 |
early growth response 1 |
|
ISO |
|
RGD |
PMID:17384085 |
RGD:5132266 |
NCBI chr23:41,139,636...41,143,598
Ensembl chr23:41,140,065...41,142,374
|
|
G |
HDAC2 |
histone deacetylase 2 |
treatment |
ISO |
|
RGD |
PMID:22708526 |
RGD:9590258 |
NCBI chr13:59,873,248...59,904,542
Ensembl chr13:59,873,767...59,905,742
|
|
G |
IFNG |
interferon gamma |
resistance |
ISO |
|
RGD |
PMID:20953328 |
RGD:4145525 |
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
|
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:serum (human) |
RGD |
PMID:20350425 |
RGD:4892019 |
NCBI chr16:29,351,214...29,361,317
|
|
G |
LOC103217855 |
C-X-C chemokine receptor type 2 |
disease_progression |
ISO |
associated with Plague |
RGD |
PMID:21356370 |
RGD:5134954 |
NCBI chr10:104,012,906...104,025,599
Ensembl chr10:104,022,811...104,023,893
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
ISO |
associated with Down Syndrome; protein:decreased secretion:serum (human) |
RGD |
PMID:19804807 |
RGD:4889483 |
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
|
|
|
G |
CD274 |
CD274 molecule |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chr12:74,038,844...74,060,662
Ensembl chr12:74,041,767...74,056,806
|
|
G |
PDCD1 |
programmed cell death 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chr10:127,877,383...127,886,234
Ensembl chr10:127,878,554...127,886,088
|
|
G |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
severity |
ISO |
|
RGD |
PMID:29893841 |
RGD:40890270 |
NCBI chr20:122,040,131...122,111,397
Ensembl chr20:122,041,963...122,078,504
|
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
|
ISO |
|
RGD |
PMID:11991282 |
RGD:4145442 |
NCBI chr16:27,792,699...27,796,437
Ensembl chr16:27,794,033...27,796,460
|
|
G |
CFTR |
CF transmembrane conductance regulator |
susceptibility |
ISO |
associated with pulmonary disease chronic obstructive; DNA:missense mutation:exon:p.R75Q(human) DNA:deletion: :F508del(human) |
RGD |
PMID:10767489 PMID:15463907 |
RGD:4140475 RGD:4140484 |
NCBI chr21:86,154,313...86,332,436
|
|
G |
CTLA4 |
cytotoxic T-lymphocyte associated protein 4 |
|
ISO |
DNA:SNPs: :multiple (human) |
RGD |
PMID:19386687 |
RGD:4891509 |
NCBI chr10:89,637,176...89,644,436
Ensembl chr10:89,638,314...89,642,344
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:15928955 |
RGD:4142512 |
NCBI chr26:8,753,236...8,759,378
Ensembl chr26:8,753,327...8,759,384
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:14593914 |
RGD:4889126 |
NCBI chr26:53,390,054...53,403,309
Ensembl chr26:53,390,089...53,404,211
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
Chronic Allergic Airway Inflammation; protein:increased secretion:bronchoalveolar lavage (mouse) |
RGD |
PMID:18631350 |
RGD:4145074 |
NCBI chr17:59,854,186...59,861,319
Ensembl chr17:59,853,699...59,861,198
|
|
G |
GC |
GC vitamin D binding protein |
susceptibility |
ISO |
|
RGD |
PMID:12096683 |
RGD:5129516 |
NCBI chr 7:20,254,604...20,298,384
Ensembl chr 7:20,253,879...20,298,265
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:bronchial epithelium (rat) |
RGD |
PMID:19507274 |
RGD:2308951 |
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
|
|
G |
IL10 |
interleukin 10 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:19507274 |
RGD:2308951 |
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:Respiratory Mucosa |
RGD |
PMID:14582911 |
RGD:4759835 |
NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11742275 |
RGD:4990461 |
NCBI chr 7:88,548,773...88,644,977
Ensembl chr 7:88,548,671...88,645,488
|
|
G |
LOC103224275 |
glutathione S-transferase Mu 1 |
severity |
ISO |
DNA:deletion: : DNA:deletion, haplotype: : (human) |
RGD |
PMID:9187680 PMID:15125256 |
RGD:12798508 RGD:4142513 |
NCBI chr20:23,854,969...23,861,634
|
|
G |
MPO |
myeloperoxidase |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11798689 |
RGD:5130990 |
NCBI chr16:35,120,194...35,130,851
Ensembl chr16:35,120,581...35,130,671
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
|
RGD |
PMID:19938219 |
RGD:4891494 |
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
|
|
G |
NPY |
neuropeptide Y |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9731035 |
|
NCBI chr21:34,068,533...34,076,205
Ensembl chr21:34,068,530...34,075,127
|
|
G |
VEGFA |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19263519 |
|
NCBI chr17:28,377,959...28,394,508
|
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
protein:increased expression:inferior turbinate, nasal gland, inflammatory cell (human) |
RGD |
PMID:8845175 |
RGD:8661738 |
NCBI chr17:59,854,186...59,861,319
Ensembl chr17:59,853,699...59,861,198
|
|
|
G |
CD8A |
CD8 subunit alpha |
ameliorates |
ISO |
protein:decreased expression:blood, T cell (human) |
RGD |
PMID:24639246 |
RGD:124715444 |
NCBI chr14:18,878,013...18,885,183
Ensembl chr14:18,878,622...18,883,885
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
protein:increased expression:uncinate process, nasal mucosa (human) |
RGD |
PMID:23613503 |
RGD:8696039 |
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
susceptibility |
ISO |
DNA:repeats:intron:IVS2+914_1000dup I/II alleles (human) |
RGD |
PMID:16549749 |
RGD:8549791 |
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
ISO |
protein:decreased activity:serum: |
RGD |
PMID:23144819 |
RGD:8693716 |
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
|
|
G |
PRG2 |
proteoglycan 2, pro eosinophil major basic protein |
disease_progression |
ISO |
associated with Nasal Polyps; |
RGD |
PMID:24450586 |
RGD:13506943 |
NCBI chr 1:15,850,181...15,854,511
Ensembl chr 1:15,850,913...15,854,517
|
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
protein:increased expression:bronchus |
RGD |
PMID:11865407 |
RGD:4890421 |
NCBI chr 9:41,085,257...41,145,760
Ensembl chr 9:41,085,361...41,145,331
|
|
G |
ALOX5AP |
arachidonate 5-lipoxygenase activating protein |
|
ISO |
protein:increased expression:bronchus |
RGD |
PMID:11865407 |
RGD:4890421 |
NCBI chr 3:9,618,030...9,642,990
Ensembl chr 3:9,617,949...9,643,184
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
associated with Pulmonary Disease, Chronic Obstructive;protein:increased expression:respiratory epithelial cell |
RGD |
PMID:20395558 |
RGD:4145446 |
NCBI chr 7:22,327,041...22,329,405
Ensembl chr 7:22,569,355...22,569,900 Ensembl chr 7:22,569,355...22,569,900
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:15764644 |
RGD:5135489 |
NCBI chr 7:24,526,657...24,529,193
Ensembl chr 7:24,526,680...24,529,130
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
treatment |
ISO |
|
RGD |
PMID:28343401 |
RGD:150521550 |
NCBI chr 7:22,202,497...22,205,730
Ensembl chr 7:22,202,527...22,204,068
|
|
G |
IFNA2 |
interferon alpha 2 |
treatment |
ISO |
|
RGD |
PMID:6381610 |
RGD:40886344 |
NCBI chr12:58,468,018...58,469,825
|
|
G |
IL10 |
interleukin 10 |
|
ISO |
|
RGD |
PMID:20696083 |
RGD:4140458 |
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:10358201 |
RGD:4143183 |
NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:7734976 |
RGD:7401200 |
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:10358201 PMID:18279051 |
RGD:4143183 RGD:4143207 |
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
|
|
G |
IL33 |
interleukin 33 |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:28471975 |
RGD:38596342 |
NCBI chr12:73,235,585...73,283,665
Ensembl chr12:73,237,406...73,252,436
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
associated with Asthma;mRNA, protein:increased expression:alveolar macrophage, respiratory system fluid/secretion |
RGD |
PMID:20644177 |
RGD:4140459 |
NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
|
|
G |
LOC103217855 |
C-X-C chemokine receptor type 2 |
|
ISO |
|
RGD |
PMID:19864593 |
RGD:5131210 |
NCBI chr10:104,012,906...104,025,599
Ensembl chr10:104,022,811...104,023,893
|
|
G |
LOC103233058 |
fractalkine |
|
ISO |
|
RGD |
PMID:20696083 |
RGD:4140458 |
NCBI chr 5:43,310,711...43,323,533
Ensembl chr 5:43,310,753...43,323,529
|
|
G |
PRDX5 |
peroxiredoxin 5 |
|
ISO |
associated with asthma;protein:increased expression:sputum (human) |
RGD |
PMID:18219526 |
RGD:41404684 |
NCBI chr 1:9,912,947...9,917,439
Ensembl chr 1:9,912,898...9,917,361
|
|
G |
TSLP |
thymic stromal lymphopoietin |
|
ISO |
protein:increased expression:nasal mucus (human) |
RGD |
PMID:28471975 |
RGD:38596342 |
NCBI chr23:14,419,820...14,423,331
|
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:lung, macrophage (human) |
RGD |
PMID:21144722 |
RGD:5131112 |
NCBI chr11:6,364,544...6,378,880
Ensembl chr11:6,364,330...6,378,902
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
|
ISO |
protein:increased expression:lung, lymphocyte (human) |
RGD |
PMID:21144722 |
RGD:5131112 |
NCBI chr20:119,590,621...119,633,562
Ensembl chr20:119,590,325...119,633,497
|
|
|
G |
SFTPC |
surfactant protein C |
|
ISO |
OMIM:263000 |
MouseDO |
|
|
NCBI chr 8:20,229,756...20,233,568
Ensembl chr 8:20,230,870...20,234,020
|
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
DNA:SNP:exon:p.G54D(rs1800450)(human) |
RGD |
PMID:15249448 |
RGD:8693755 |
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
protein:decreased expression:bronchiole epithelium |
RGD |
PMID:15364771 |
RGD:7364741 |
NCBI chr 1:981,515...1,018,242
|
|
G |
MUC5B |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
DNA:insertion/deletion |
RGD |
PMID:15709052 |
RGD:7349353 |
NCBI chr 1:1,040,756...1,083,246
Ensembl chr 1:1,042,110...1,081,240
|
|
G |
MUCL3 |
mucin like 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22152429 |
|
NCBI chr17:41,510,045...41,525,120
|
|
G |
TAP2 |
transporter 2, ATP binding cassette subfamily B member |
susceptibility |
ISO |
DNA:polymorphisms:exon: |
RGD |
PMID:10323341 |
RGD:5147847 |
NCBI chr17:39,266,870...39,277,658
|
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
|
ISO |
protein:increased expression:ethmoid sinus |
RGD |
PMID:9800627 |
RGD:6483785 |
NCBI chr16:27,777,795...27,780,413
|
|
|
G |
C5 |
complement C5 |
|
ISO |
|
RGD |
PMID:2612053 |
RGD:5130160 |
NCBI chr12:18,525,855...18,624,048
Ensembl chr12:18,525,880...18,623,636
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
|
ISO |
|
RGD |
PMID:20045013 |
RGD:5129686 |
NCBI chr16:27,777,795...27,780,413
|
|
G |
GATA2 |
GATA binding protein 2 |
|
ISO |
associated with Pneumocystis Infections |
RGD |
PMID:16774119 |
RGD:9587813 |
NCBI chr22:52,549,112...52,562,911
Ensembl chr22:52,555,738...52,562,909
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:16544260 PMID:19752036 |
RGD:4145474 RGD:4145506 |
NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
|
|
G |
IL33 |
interleukin 33 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:25746970 |
RGD:39938968 |
NCBI chr12:73,235,585...73,283,665
Ensembl chr12:73,237,406...73,252,436
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:10639453 |
RGD:4891455 |
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
|
|
G |
SFTPD |
surfactant protein D |
susceptibility |
ISO |
|
RGD |
PMID:20413160 |
RGD:4143489 |
NCBI chr 9:51,809,241...51,820,974
Ensembl chr 9:51,811,052...51,820,650
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:16544260 |
RGD:4145506 |
|
|
|
G |
ABO |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
susceptibility |
ISO |
DNA:polymorphism:cds:allele AB (human) |
RGD |
PMID:4375858 PMID:6189297 |
RGD:39938844 RGD:5128836 |
NCBI chr12:4,863,100...4,892,204
Ensembl chr12:4,863,165...4,885,849
|
|
G |
APOL6 |
apolipoprotein L6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr19:18,406,771...18,431,437
Ensembl chr19:18,406,678...18,422,088
|
|
G |
ATF3 |
activating transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr25:16,910,312...16,922,598
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:21408070 |
RGD:5129492 |
NCBI chr 6:6,250,422...6,289,264
|
|
G |
CASP1 |
caspase 1 |
|
ISO |
|
RGD |
PMID:19362023 |
RGD:5130181 |
NCBI chr 1:96,389,697...96,400,610
Ensembl chr 1:96,389,657...96,400,849
|
|
G |
CAT |
catalase |
|
ISO |
|
RGD |
PMID:16804020 PMID:19959187 PMID:20653246 |
RGD:5130201 RGD:5130744 RGD:5130864 |
NCBI chr 1:30,792,533...30,828,920
Ensembl chr 1:30,792,399...30,829,592
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
|
ISO |
associated with Asthma;protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12707338 PMID:20656925 |
RGD:4145439 RGD:4145452 |
NCBI chr16:27,792,699...27,796,437
Ensembl chr16:27,794,033...27,796,460
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20967263 PMID:23326326 |
RGD:4891425 |
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
|
|
G |
CCL28 |
C-C motif chemokine ligand 28 |
resistance |
ISO |
|
RGD |
PMID:19847203 |
RGD:4892196 |
NCBI chr 4:42,163,094...42,194,517
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
susceptibility |
ISO |
protein:increased expression:lung (mouse) |
RGD |
PMID:16208318 PMID:20656925 |
RGD:4145452 RGD:4892131 |
NCBI chr16:29,351,214...29,361,317
|
|
G |
CCL8 |
C-C motif chemokine ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr16:27,821,149...27,823,919
Ensembl chr16:27,821,970...27,823,528
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
severity |
ISO |
DNA:frameshift mutation:cds:p.S185_T195del rs333 (human) |
RGD |
PMID:18617426 PMID:19039768 PMID:20875295 |
RGD:4892063 RGD:4892119 RGD:4892122 |
NCBI chr22:7,803,794...7,818,112
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:17825924 |
RGD:4144809 |
NCBI chr23:43,264,917...43,266,825
Ensembl chr23:43,264,336...43,266,993
|
|
G |
CD209 |
CD209 molecule |
susceptibility |
ISO |
|
RGD |
PMID:21191006 |
RGD:5131189 |
NCBI chr 6:7,219,576...7,235,755
Ensembl chr 6:7,228,378...7,235,208
|
|
G |
CD28 |
CD28 molecule |
|
ISO |
|
RGD |
PMID:21389258 |
RGD:5131611 |
NCBI chr10:89,471,710...89,505,152
Ensembl chr10:89,471,730...89,500,387
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:19922665 |
RGD:5132270 |
NCBI chr 2:17,753,713...17,765,134
Ensembl chr 2:17,753,394...17,764,566
|
|
G |
CD80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:10604996 PMID:19922665 |
RGD:5132270 RGD:5132623 |
NCBI chr22:61,258,281...61,294,772
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
protein:increased expression:mediastinal lymph node, B cell (mouse) |
RGD |
PMID:19933871 |
RGD:4892570 |
NCBI chr22:58,741,534...58,805,417
Ensembl chr22:58,741,525...58,805,366
|
|
G |
CRP |
C-reactive protein |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21509252 |
RGD:5131277 |
NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO |
|
RGD |
PMID:20427198 PMID:21474645 |
RGD:5131470 RGD:5131472 |
NCBI chr23:34,906,987...34,911,252
Ensembl chr23:34,908,911...34,911,140
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion protein:increased expression:lung, serum |
RGD |
PMID:17348295 PMID:20656925 |
RGD:4145366 RGD:4145452 |
NCBI chr 7:22,327,041...22,329,405
Ensembl chr 7:22,569,355...22,569,900 Ensembl chr 7:22,569,355...22,569,900
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 7:24,526,657...24,529,193
Ensembl chr 7:24,526,680...24,529,130
|
|
G |
DDX60 |
DExD/H-box helicase 60 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 7:114,474,678...114,578,749
Ensembl chr 7:114,474,680...114,578,563
|
|
G |
EGR1 |
early growth response 1 |
|
ISO |
mRNA:increased expression:frontal cortex (mouse) |
RGD |
PMID:21289196 |
RGD:5131660 |
NCBI chr23:41,139,636...41,143,598
Ensembl chr23:41,140,065...41,142,374
|
|
G |
EIF2AK2 |
eukaryotic translation initiation factor 2 alpha kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr14:70,246,081...70,290,851
Ensembl chr14:70,247,168...70,296,463
|
|
G |
FOXP2 |
forkhead box P2 |
|
ISO |
|
RGD |
PMID:18248790 |
RGD:11536002 |
NCBI chr21:82,799,147...83,392,568
Ensembl chr21:83,129,308...83,389,483
|
|
G |
HERC5 |
HECT and RLD domain containing E3 ubiquitin protein ligase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 7:36,817,118...36,867,712
Ensembl chr 7:36,819,708...36,867,933
|
|
G |
HERC6 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 7:36,739,524...36,803,493
Ensembl chr 7:36,739,566...36,803,915
|
|
G |
IFI27 |
interferon alpha inducible protein 27 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr24:71,884,130...71,890,813
|
|
G |
IFI35 |
interferon induced protein 35 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr16:63,276,493...63,284,196
Ensembl chr16:63,273,829...63,284,283
|
|
G |
IFI44 |
interferon induced protein 44 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr20:54,539,512...54,554,787
Ensembl chr20:54,539,392...54,554,785
|
|
G |
IFI44L |
interferon induced protein 44 like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr20:54,563,728...54,586,018
Ensembl chr20:54,561,775...54,586,030
|
|
G |
IFI6 |
interferon alpha inducible protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr20:105,118,969...105,125,037
Ensembl chr20:105,118,645...105,125,151
|
|
G |
IFIH1 |
interferon induced with helicase C domain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr10:47,676,799...47,732,310
Ensembl chr10:47,676,920...47,732,264
|
|
G |
IFIT1 |
interferon induced protein with tetratricopeptide repeats 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 9:82,778,546...82,797,678
Ensembl chr 9:82,785,898...82,798,621
|
|
G |
IFIT2 |
interferon induced protein with tetratricopeptide repeats 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 9:82,711,647...82,718,983
Ensembl chr 9:82,711,612...82,718,973
|
|
G |
IFIT3 |
interferon induced protein with tetratricopeptide repeats 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 9:82,738,747...82,750,134
Ensembl chr 9:82,743,001...82,751,309
|
|
G |
IFIT5 |
interferon induced protein with tetratricopeptide repeats 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 9:82,801,437...82,806,890
Ensembl chr 9:82,800,825...82,805,599
|
|
G |
IL10 |
interleukin 10 |
susceptibility |
ISO |
|
RGD |
PMID:20200252 |
RGD:4140426 |
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
|
|
G |
IL12B |
interleukin 12B |
|
ISO |
|
RGD |
PMID:16389596 |
RGD:4145426 |
NCBI chr23:61,714,293...61,731,835
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20003352 |
RGD:4888530 |
NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:19234203 PMID:20212069 PMID:21098221 |
RGD:4994196 RGD:4996471 RGD:4996472 |
NCBI chr 7:88,548,773...88,644,977
Ensembl chr 7:88,548,671...88,645,488
|
|
G |
IL15RA |
interleukin 15 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:21098221 |
RGD:4994196 |
NCBI chr 9:6,061,475...6,096,370
Ensembl chr 9:6,061,197...6,096,250
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:19265125 PMID:19783685 |
RGD:4889102 RGD:4889150 |
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:15606801 |
RGD:4889964 |
NCBI chr 1:103,485,868...103,511,632
Ensembl chr 1:103,482,083...103,510,150
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11535264 |
RGD:4142860 |
NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
|
RGD |
PMID:20438620 |
RGD:4142822 |
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
disease_progression |
ISO |
protein:increased expression:serum |
RGD |
PMID:9439800 PMID:20840779 |
RGD:4143203 RGD:4143228 |
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
|
|
G |
IL2 |
interleukin 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21603856 |
RGD:5147905 |
NCBI chr 7:69,729,635...69,736,279
Ensembl chr 7:69,730,282...69,734,969
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
|
RGD |
PMID:21092162 |
RGD:5128546 |
NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
|
RGD |
PMID:20731583 |
RGD:4143268 |
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
|
|
G |
IRF7 |
interferon regulatory factor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:430,412...433,959
Ensembl chr 1:429,310...432,925
|
|
G |
ISG15 |
ISG15 ubiquitin like modifier |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr20:130,419,909...130,421,409
Ensembl chr20:130,419,782...130,421,380
|
|
G |
LAMP3 |
lysosomal associated membrane protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr15:6,245,146...6,285,481
|
|
G |
LOC103238550 |
interferon-induced transmembrane protein 3 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Influenza, severe, susceptibility to |
OMIM ClinVar |
PMID:20943977 PMID:22446628 |
|
NCBI chr 1:147,228...148,078
|
|
G |
LOC103248572 |
transmembrane serine protease 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26889029 |
|
NCBI chr 1:109,449,920...109,497,169
Ensembl chr 1:109,470,496...109,495,224
|
|
G |
LY6E |
lymphocyte antigen 6 family member E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 8:137,265,510...137,269,397
Ensembl chr 8:137,265,535...137,269,404
|
|
G |
LYST |
lysosomal trafficking regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26597256 |
|
NCBI chr25:72,827,997...73,048,645
Ensembl chr25:72,828,006...72,991,970
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased activity:lung, heart, brain |
RGD |
PMID:20299740 |
RGD:5130855 |
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
|
|
G |
MX1 |
MX dynamin like GTPase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:85,333,327...85,368,179
Ensembl chr 2:85,338,530...85,368,507
|
|
G |
MX2 |
MX dynamin like GTPase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:85,281,752...85,326,736
Ensembl chr 2:85,289,689...85,326,735
|
|
G |
NOS1 |
nitric oxide synthase 1 |
|
ISO |
protein:increased expression:hippocampus |
RGD |
PMID:9552178 |
RGD:5132870 |
NCBI chr11:112,642,374...112,673,882
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
mRNA,protein:increased expression:brain mRNA:increased expression:olfactory epithelium |
RGD |
PMID:17030871 PMID:17674769 PMID:18080188 |
RGD:4891919 RGD:4891937 RGD:4891952 |
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
|
|
G |
OAS1 |
2'-5'-oligoadenylate synthetase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr11:108,163,203...108,176,191
Ensembl chr11:108,163,299...108,176,193
|
|
G |
OAS2 |
2'-5'-oligoadenylate synthetase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr11:108,218,645...108,251,485
Ensembl chr11:108,218,665...108,252,836
|
|
G |
OAS3 |
2'-5'-oligoadenylate synthetase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr11:108,192,595...108,210,332
Ensembl chr11:108,192,509...108,213,333
|
|
G |
OASL |
2'-5'-oligoadenylate synthetase like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr11:116,376,806...116,396,239
Ensembl chr11:116,376,217...116,395,945
|
|
G |
PARP12 |
poly(ADP-ribose) polymerase family member 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr21:108,783,333...108,826,392
Ensembl chr21:108,783,323...108,825,527
|
|
G |
PLSCR1 |
phospholipid scramblase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr15:44,160,017...44,189,056
Ensembl chr15:44,160,200...44,188,195
|
|
G |
PRF1 |
perforin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26597256 |
|
NCBI chr 9:60,692,544...60,698,000
Ensembl chr 9:60,692,600...60,698,465
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:16272346 |
RGD:5143925 |
NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
|
|
G |
RIGI |
RNA sensor RIG-I |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr12:47,729,040...47,800,995
Ensembl chr12:47,729,076...47,799,570
|
|
G |
RSAD2 |
radical S-adenosyl methionine domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr14:100,778,801...100,804,205
Ensembl chr14:100,778,302...100,798,044
|
|
G |
RTP4 |
receptor transporter protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr15:81,639,422...81,643,045
Ensembl chr15:81,639,669...81,643,058
|
|
G |
SAMD9 |
sterile alpha motif domain containing 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr21:55,895,799...55,913,845
Ensembl chr21:55,907,249...55,912,015
|
|
G |
SCO2 |
SCO2, cytochrome c oxidase assembly protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr19:32,995,153...32,997,249
Ensembl chr19:32,995,196...32,995,996
|
|
G |
SERPING1 |
serpin family G member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:15,617,122...15,634,540
Ensembl chr 1:15,616,674...15,633,855
|
|
G |
SFTPD |
surfactant protein D |
|
ISO |
|
RGD |
PMID:16787926 |
RGD:4143518 |
NCBI chr 9:51,809,241...51,820,974
Ensembl chr 9:51,811,052...51,820,650
|
|
G |
SIGLEC1 |
sialic acid binding Ig like lectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:34,371,605...34,417,105
Ensembl chr 2:34,371,519...34,392,034
|
|
G |
SLC22A8 |
solute carrier family 22 member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23129053 |
|
NCBI chr 1:10,885,895...10,909,739
Ensembl chr 1:10,886,690...10,910,546
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr10:76,492,859...76,537,689
Ensembl chr10:76,492,533...76,533,393
|
|
G |
TDRD7 |
tudor domain containing 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr12:41,903,454...41,984,534
Ensembl chr12:41,903,448...41,984,442
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
protein:increased expression:monocyte |
RGD |
PMID:18657324 |
RGD:4145339 |
NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
|
|
G |
TLR3 |
toll like receptor 3 |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:16789835 PMID:18654661 |
RGD:5129136 RGD:5129219 |
NCBI chr 7:131,991,068...132,014,366
Ensembl chr 7:131,991,029...132,016,232
|
|
G |
TMPRSS11D |
transmembrane serine protease 11D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20237084 PMID:23072892 |
|
NCBI chr 7:1,076,592...1,146,080
Ensembl chr 7:1,106,307...1,145,673
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21062445 |
RGD:5128683 |
|
|
G |
TNFAIP6 |
TNF alpha induced protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr10:36,792,505...36,814,271
Ensembl chr10:36,792,514...36,814,494
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:17182684 PMID:19497758 |
RGD:5131157 RGD:5131432 |
NCBI chr11:6,364,544...6,378,880
Ensembl chr11:6,364,330...6,378,902
|
|
G |
TNFSF10 |
TNF superfamily member 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr15:16,934,982...16,953,155
Ensembl chr15:16,934,962...16,954,860
|
|
G |
TOR1B |
torsin family 1 member B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr12:8,327,388...8,334,019
Ensembl chr12:8,327,595...8,333,950
|
|
G |
TREX1 |
three prime repair exonuclease 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr22:9,869,502...9,871,659
|
|
G |
TRIM22 |
tripartite motif containing 22 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:61,018,252...61,036,690
Ensembl chr 1:61,019,464...61,036,548
|
|
G |
UBE2L6 |
ubiquitin conjugating enzyme E2 L6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:15,667,026...15,680,603
Ensembl chr 1:15,667,009...15,681,602
|
|
G |
UGCG |
UDP-glucose ceramide glucosyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33639165 |
|
NCBI chr12:27,575,519...27,614,114
Ensembl chr12:27,574,970...27,613,811
|
|
G |
XAF1 |
XIAP associated factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr16:6,117,228...6,135,535
Ensembl chr16:6,118,094...6,134,902
|
|
G |
ZCCHC2 |
zinc finger CCHC-type containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr18:17,186,456...17,244,639
Ensembl chr18:17,177,964...17,244,574
|
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:lung, alveolar macrophage (human) |
RGD |
PMID:19218648 |
RGD:4145518 |
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
protein:increased expression:bronchoalveolar lavage (rat) |
RGD |
PMID:10988147 |
RGD:11062092 |
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
|
ISO |
protein:increased expression:hyperplastic lung epithelium, alveolus (human) |
RGD |
PMID:20718723 |
RGD:6893300 |
NCBI chr 6:9,515,789...9,526,699
Ensembl chr 6:9,515,416...9,522,797
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
|
ISO |
|
RGD |
PMID:21444868 |
RGD:7245946 |
NCBI chr20:120,522,667...120,678,988
Ensembl chr20:120,525,737...120,679,020
|
|
G |
SCGB1A1 |
secretoglobin family 1A member 1 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:15467329 |
RGD:5144148 |
NCBI chr 1:11,470,091...11,474,915
Ensembl chr 1:11,470,195...11,474,149
|
|
G |
TERT |
telomerase reverse transcriptase |
|
ISO |
ClinVar Annotator: match by term: idiopathic fibrosing alveolitis |
ClinVar |
PMID:9536098 PMID:15814878 PMID:15885610 PMID:16247010 PMID:17460043 PMID:17576681 PMID:18042801 PMID:18460650 PMID:18635888 PMID:18931339 PMID:19561322 PMID:19674077 PMID:19760749 PMID:20301779 PMID:20502709 PMID:21436073 PMID:21483807 PMID:21520174 PMID:21602826 PMID:22853774 PMID:23538340 PMID:23716176 PMID:23901009 PMID:24033266 PMID:24763404 PMID:24833766 PMID:24983628 PMID:25346280 PMID:25365545 PMID:25741868 PMID:25785092 PMID:26024875 PMID:26136524 PMID:26580448 PMID:26859482 PMID:27192671 PMID:27418648 PMID:27540018 PMID:27848944 PMID:28104920 PMID:28492532 PMID:29036293 PMID:29483670 PMID:30426156 PMID:30523342 PMID:30791107 PMID:31268371 PMID:33709208 PMID:33850299 PMID:34019641 PMID:34482403 PMID:34565437 PMID:34890115 PMID:35106810 PMID:35776903 PMID:36622818 PMID:37096215 More...
|
|
NCBI chr 4:1,082,894...1,119,373
Ensembl chr 4:1,083,384...1,117,468
|
|
|
G |
ATM |
ATM serine/threonine kinase |
exacerbates |
ISO |
|
RGD |
PMID:31509427 |
RGD:126779564 |
NCBI chr 1:99,653,208...99,786,889
Ensembl chr 1:99,653,139...99,791,520
|
|
G |
BTK |
Bruton tyrosine kinase |
ameliorates |
ISO |
Associated with Acute Lung Injury |
RGD |
PMID:29516781 |
RGD:124713566 |
NCBI chr X:89,690,569...89,727,420
|
|
G |
DUOX1 |
dual oxidase 1 |
|
ISO |
protein:decreased expression:blood plasma (human) |
RGD |
PMID:24888898 |
RGD:40903071 |
NCBI chr26:38,038,093...38,073,993
Ensembl chr26:38,038,771...38,072,023
|
|
G |
DUOX2 |
dual oxidase 2 |
severity |
ISO |
|
RGD |
PMID:25751630 PMID:28936773 PMID:29556357 |
RGD:40924644 RGD:40925921 RGD:40925925 |
NCBI chr26:38,090,053...38,110,781
Ensembl chr26:38,090,648...38,109,636
|
|
G |
IFIH1 |
interferon induced with helicase C domain 1 |
|
ISO |
mRNA:increased expression:nasal cavity mucosa (mouse) |
RGD |
PMID:25751630 |
RGD:40925925 |
NCBI chr10:47,676,799...47,732,310
Ensembl chr10:47,676,920...47,732,264
|
|
G |
IL21 |
interleukin 21 |
|
ISO |
|
RGD |
PMID:25251568 |
RGD:127285548 |
NCBI chr 7:69,859,793...69,872,237
Ensembl chr 7:69,863,535...69,872,025
|
|
G |
IL27 |
interleukin 27 |
|
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:22343630 |
RGD:126790513 |
NCBI chr 5:26,348,559...26,358,028
Ensembl chr 5:26,348,848...26,356,360
|
|
G |
MAP3K8 |
mitogen-activated protein kinase kinase kinase 8 |
exacerbates |
ISO |
|
RGD |
PMID:26241898 |
RGD:11055126 |
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
ameliorates |
ISO |
|
RGD |
PMID:22514650 |
RGD:150340681 |
NCBI chr 9:43,356,603...43,489,066
Ensembl chr 9:43,356,308...43,393,425
|
|
G |
MARCO |
macrophage receptor with collagenous structure |
ameliorates |
ISO |
|
RGD |
PMID:21562316 |
RGD:41412197 |
NCBI chr10:11,329,036...11,389,428
Ensembl chr10:11,329,026...11,388,999
|
|
G |
MAVS |
mitochondrial antiviral signaling protein |
disease_progression |
ISO |
|
RGD |
PMID:27438481 |
RGD:40903047 |
NCBI chr 2:34,534,433...34,555,406
Ensembl chr 2:34,541,229...34,552,823
|
|
G |
MX1 |
MX dynamin like GTPase 1 |
ameliorates |
ISO |
human gene in a mouse model |
RGD |
PMID:30945621 PMID:31653718 |
RGD:126777673 RGD:126777680 |
NCBI chr 2:85,333,327...85,368,179
Ensembl chr 2:85,338,530...85,368,507
|
|
G |
PLAC8 |
placenta associated 8 |
|
ISO |
|
RGD |
PMID:32639988 |
RGD:40925929 |
NCBI chr 7:31,471,166...31,496,053
Ensembl chr 7:31,470,774...31,489,432
|
|
G |
PPIA |
peptidylprolyl isomerase A |
ameliorates |
ISO |
human gene in a mouse model |
RGD |
PMID:27354005 |
RGD:150429624 |
NCBI chr21:13,876,099...13,883,546
Ensembl chr21:13,876,099...13,883,462
|
|
G |
RIGI |
RNA sensor RIG-I |
|
ISO |
mRNA:increased expression:nasal cavity mucosa (mouse) |
RGD |
PMID:25751630 |
RGD:40925925 |
NCBI chr12:47,729,040...47,800,995
Ensembl chr12:47,729,076...47,799,570
|
|
G |
RIPK3 |
receptor interacting serine/threonine kinase 3 |
exacerbates susceptibility |
ISO |
|
RGD |
PMID:27321907 PMID:28410401 PMID:32200799 |
RGD:127229911 RGD:127229918 RGD:127229922 |
NCBI chr24:1,318,265...1,322,610
Ensembl chr24:1,318,216...1,322,462
|
|
G |
STAT2 |
signal transducer and activator of transcription 2 |
exacerbates |
ISO |
|
RGD |
PMID:30337919 |
RGD:41789626 |
NCBI chr11:52,297,890...52,316,089
Ensembl chr11:52,297,543...52,316,105
|
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
|
ISO |
|
RGD |
PMID:21423669 |
RGD:5508765 |
NCBI chr17:39,847,343...39,851,288
Ensembl chr17:39,847,759...39,851,127
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
severity |
ISO |
|
RGD |
PMID:11160230 |
RGD:11528533 |
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
|
|
G |
CCL20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:20926800 |
RGD:7483599 |
NCBI chr10:113,815,099...113,836,562
Ensembl chr10:113,832,573...113,835,736
|
|
G |
CCR6 |
C-C motif chemokine receptor 6 |
disease_progression |
ISO |
|
RGD |
PMID:17379855 |
RGD:7483617 |
NCBI chr13:94,865,480...94,894,331
Ensembl chr13:94,865,936...94,894,315
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:17298426 |
RGD:5135501 |
NCBI chr X:61,430,723...61,433,777
Ensembl chr X:61,430,725...61,433,386
|
|
G |
CYBB |
cytochrome b-245 heavy chain |
|
ISO |
|
RGD |
PMID:24054721 |
RGD:10450528 |
|
|
G |
CYP2C19 |
cytochrome P450 family 2 subfamily C member 19 |
treatment |
ISO |
DNA:polymorphisms:cds: |
RGD |
PMID:26861072 |
RGD:124713410 |
NCBI chr 9:87,981,300...88,025,007
|
|
G |
ELANE |
elastase, neutrophil expressed |
|
ISO |
|
RGD |
PMID:24054721 |
RGD:10450528 |
NCBI chr 6:599,392...604,925
Ensembl chr 6:601,217...604,725
|
|
G |
IL17A |
interleukin 17A |
severity |
ISO |
|
RGD |
PMID:21807912 |
RGD:8698654 |
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
ISO |
DNA:SNP:exon:rs5030737(human) |
RGD |
PMID:17311505 |
RGD:8693758 |
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
|
|
G |
PTX3 |
pentraxin 3 |
severity |
ISO |
protein:increased expression:bronchoalveolar lavage fluid (human) DNA:SNPs, missense mutation:intron, cds:rs2305619, rs1840680, rs3816527 |
RGD |
PMID:28487045 PMID:30275011 |
RGD:38501097 RGD:38508892 |
NCBI chr15:33,320,592...33,327,236
Ensembl chr15:33,321,208...33,327,268
|
|
G |
S100B |
S100 calcium binding protein B |
|
ISO |
|
RGD |
PMID:21423669 |
RGD:5508765 |
NCBI chr 2:90,188,820...90,194,986
Ensembl chr 2:90,188,639...90,195,023
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:16113258 |
RGD:8553022 |
NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
|
|
G |
TLR4 |
toll like receptor 4 |
susceptibility |
ISO |
DNA:polymorphism:exon:p.D299G(human) |
RGD |
PMID:18275280 |
RGD:5130863 |
NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
|
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
treatment |
ISO |
|
RGD |
PMID:12917249 |
RGD:11528529 |
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
|
|
G |
CD209 |
CD209 molecule |
susceptibility |
ISO |
DNA:SNPs:3'utr,intron:multiple |
RGD |
PMID:22384201 |
RGD:39938996 |
NCBI chr 6:7,219,576...7,235,755
Ensembl chr 6:7,228,378...7,235,208
|
|
G |
FGF2 |
fibroblast growth factor 2 |
treatment |
ISO |
|
RGD |
PMID:23303813 |
RGD:8655596 |
NCBI chr 7:70,089,394...70,157,423
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
DNA:polymorphism, haplotype:promoter:-889C>T (human) |
RGD |
PMID:18484169 |
RGD:4142867 |
NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
DNA:polymorphism, haplotype: :-511C>T (human) |
RGD |
PMID:18484169 |
RGD:4142867 |
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
|
|
G |
ITIH4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion, serum |
RGD |
PMID:24360996 |
RGD:40903005 |
NCBI chr22:14,194,979...14,216,180
Ensembl chr22:14,195,701...14,213,603
|
|
G |
MBL2 |
mannose binding lectin 2 |
treatment |
ISO |
|
RGD |
PMID:17335555 |
RGD:8693746 |
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
|
|
G |
PTX3 |
pentraxin 3 |
susceptibility no_association |
ISO |
DNA:SNP:intron:rs1840680 (human) DNA:SNP, missense mutation:intron, cds:rs2305619, rs3816527 protein:increased expression:bronchoalveolar lavage fluid, plasma (human) protein:increased expression:plasma |
RGD |
PMID:29020397 PMID:29964232 |
RGD:38501098 RGD:38508894 |
NCBI chr15:33,320,592...33,327,236
Ensembl chr15:33,321,208...33,327,268
|
|
G |
VEGFA |
vascular endothelial growth factor A |
treatment |
ISO |
|
RGD |
PMID:23303813 |
RGD:8655596 |
NCBI chr17:28,377,959...28,394,508
|
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
|
RGD |
PMID:11207292 |
RGD:38549344 |
NCBI chr 7:22,202,497...22,205,730
Ensembl chr 7:22,202,527...22,204,068
|
|
G |
IL23A |
interleukin 23 subunit alpha |
severity |
ISO |
|
RGD |
PMID:16157683 |
RGD:39457940 |
NCBI chr11:52,289,486...52,296,735
Ensembl chr11:52,295,106...52,297,244
|
|
G |
IRAK3 |
interleukin 1 receptor associated kinase 3 |
severity |
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:20864681 PMID:22729155 |
RGD:35316077 RGD:36049798 |
NCBI chr11:61,868,817...61,920,896
Ensembl chr11:61,869,173...61,920,406
|
|
G |
LCN2 |
lipocalin 2 |
ameliorates exacerbates |
ISO |
protein:increased expression:serum protein:increased expression:lung |
RGD |
PMID:19342674 PMID:25234944 PMID:29633303 |
RGD:126725082 RGD:126725084 RGD:126725085 |
NCBI chr12:9,976,278...9,981,087
Ensembl chr12:9,976,614...9,980,870
|
|
G |
PLAC8 |
placenta associated 8 |
severity |
ISO |
|
RGD |
PMID:17404296 |
RGD:40924563 |
NCBI chr 7:31,471,166...31,496,053
Ensembl chr 7:31,470,774...31,489,432
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
disease_progression |
ISO |
|
RGD |
PMID:24396044 |
RGD:126925976 |
NCBI chr17:30,873,647...30,885,292
Ensembl chr17:30,873,666...30,886,967
|
|
|
G |
ADA |
adenosine deaminase |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9255891 |
RGD:5128857 |
NCBI chr 2:19,167,209...19,200,233
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 7:22,327,041...22,329,405
Ensembl chr 7:22,569,355...22,569,900 Ensembl chr 7:22,569,355...22,569,900
|
|
G |
CXCL6 |
C-X-C motif chemokine ligand 6 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 7:22,291,949...22,294,191
Ensembl chr 7:22,292,045...22,294,207
|
|
G |
IFNG |
interferon gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11349020 |
|
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:11083766 |
RGD:4889865 |
NCBI chr 1:103,485,868...103,511,632
Ensembl chr 1:103,482,083...103,510,150
|
|
G |
LOC103217855 |
C-X-C chemokine receptor type 2 |
|
ISO |
|
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr10:104,012,906...104,025,599
Ensembl chr10:104,022,811...104,023,893
|
|
G |
LOC103233058 |
fractalkine |
|
ISO |
|
RGD |
PMID:16113250 |
RGD:4891897 |
NCBI chr 5:43,310,711...43,323,533
Ensembl chr 5:43,310,753...43,323,529
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
|
RGD |
PMID:19073229 |
RGD:12910934 |
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
|
|
G |
NOD1 |
nucleotide binding oligomerization domain containing 1 |
|
ISO |
|
RGD |
PMID:20685341 |
RGD:5131443 |
NCBI chr21:27,907,628...27,957,621
Ensembl chr21:27,926,710...27,957,619
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:20685341 |
RGD:5131443 |
NCBI chr 5:36,492,158...36,531,766
Ensembl chr 5:36,496,414...36,530,499
|
|
G |
TLR5 |
toll like receptor 5 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Legionnaire disease, susceptibility to |
ClinVar OMIM |
PMID:14623910 PMID:16027372 PMID:23447684 |
|
NCBI chr25:6,418,895...6,440,433
Ensembl chr25:6,437,638...6,440,211
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
|
RGD |
PMID:18838275 |
RGD:5131445 |
NCBI chr11:6,364,544...6,378,880
Ensembl chr11:6,364,330...6,378,902
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
|
ISO |
|
RGD |
PMID:18838275 |
RGD:5131445 |
NCBI chr20:119,590,621...119,633,562
Ensembl chr20:119,590,325...119,633,497
|
|
|
G |
ADA |
adenosine deaminase |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9255891 |
RGD:5128857 |
NCBI chr 2:19,167,209...19,200,233
|
|
G |
ATP1B2 |
ATPase Na+/K+ transporting subunit beta 2 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr16:7,030,016...7,035,620
Ensembl chr16:7,030,055...7,037,754
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:lung, secretion (mouse) |
RGD |
PMID:18717637 |
RGD:4891914 |
NCBI chr16:29,351,214...29,361,317
|
|
G |
CCL8 |
C-C motif chemokine ligand 8 |
|
ISO |
|
RGD |
PMID:16988274 |
RGD:4892091 |
NCBI chr16:27,821,149...27,823,919
Ensembl chr16:27,821,970...27,823,528
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
protein:increased expression:lung, T-helper cell (mouse) |
RGD |
PMID:16988274 |
RGD:4892091 |
NCBI chr22:7,803,794...7,818,112
|
|
G |
CLEC5A |
C-type lectin domain containing 5A |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr21:110,629,443...110,650,350
Ensembl chr21:110,632,181...110,649,204
|
|
G |
COL3A1 |
collagen type III alpha 1 chain |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr10:74,455,133...74,493,392
|
|
G |
COL6A1 |
collagen type VI alpha 1 chain |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 2:89,608,525...89,649,823
|
|
G |
COL6A2 |
collagen type VI alpha 2 chain |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 2:89,724,355...89,758,389
Ensembl chr 2:89,737,003...89,758,425
|
|
G |
CRP |
C-reactive protein |
|
ISO |
|
RGD |
PMID:21426633 |
RGD:5131292 |
NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
|
|
G |
DNASE1L3 |
deoxyribonuclease 1L3 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr22:19,487,767...19,496,019
Ensembl chr22:19,487,596...19,496,129
|
|
G |
FCER2 |
Fc fragment of IgE receptor II |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 6:7,175,032...7,189,002
Ensembl chr 6:7,175,032...7,189,057
|
|
G |
FLT1 |
fms related receptor tyrosine kinase 1 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 3:7,412,506...7,608,122
Ensembl chr 3:7,412,172...7,607,967
|
|
G |
GALC |
galactosylceramidase |
|
ISO |
protein:increased expression:serum (mouse) associated with Guillain-Barre syndrome; protein:increased expression:Cerebrospinal fluid, serum (human) associated with Guillain-Barre syndrome; protein:increased expression:serum (human) |
RGD |
PMID:12225900 PMID:27490360 PMID:29301655 PMID:30396892 |
RGD:38599168 RGD:38599169 RGD:38599171 RGD:38599172 |
NCBI chr24:65,556,763...65,621,693
Ensembl chr24:65,558,074...65,621,258
|
|
G |
HDC |
histidine decarboxylase |
|
ISO |
|
RGD |
PMID:17158962 |
RGD:5143920 |
NCBI chr26:33,051,048...33,074,872
Ensembl chr26:33,051,966...33,074,563
|
|
G |
HTRA3 |
HtrA serine peptidase 3 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr27:44,214,635...44,252,673
Ensembl chr27:44,214,874...44,252,732
|
|
G |
IFNG |
interferon gamma |
|
ISO |
mRNA:increased expression:lung: |
RGD |
PMID:7935058 |
RGD:10755754 |
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20416219 |
RGD:4145765 |
NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
|
|
G |
IL22RA2 |
interleukin 22 receptor subunit alpha 2 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr13:36,254,113...36,273,279
Ensembl chr13:36,255,116...36,271,258
|
|
G |
INHBA |
inhibin subunit beta A |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr21:16,936,054...16,951,430
Ensembl chr21:16,936,175...16,946,880
|
|
G |
KLRF1 |
killer cell lectin like receptor F1 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr11:9,715,900...9,731,454
Ensembl chr11:9,716,010...9,731,387
|
|
G |
MS4A1 |
membrane spanning 4-domains A1 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 1:13,343,647...13,358,639
Ensembl chr 1:13,345,253...13,358,547
|
|
G |
PLD4 |
phospholipase D family member 4 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr24:82,848,775...82,857,359
Ensembl chr24:82,851,238...82,857,579
|
|
G |
TCF7 |
transcription factor 7 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr23:36,919,648...36,953,088
Ensembl chr23:36,919,745...36,951,192
|
|
G |
TCL1A |
TCL1 family AKT coactivator A |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr24:73,556,188...73,570,376
Ensembl chr24:73,566,270...73,570,348
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20416219 |
RGD:4145765 |
|
|
G |
TNFRSF13C |
TNF receptor superfamily member 13C |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr19:24,457,381...24,459,438
|
|
|
G |
LOC103219825 |
protein patched homolog 1 |
|
ISO |
mRNA:decreased expression:epithelium of nasopharynx |
RGD |
PMID:23001130 |
RGD:150523839 |
NCBI chr12:107,580,895...107,656,443
Ensembl chr12:107,590,663...107,652,985
|
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:19725899 |
RGD:5686851 |
NCBI chr15:81,128,427...81,142,779
Ensembl chr15:81,129,795...81,147,391
|
|
G |
ALB |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19389874 |
|
NCBI chr 7:21,872,036...21,890,095
Ensembl chr 7:21,876,132...21,891,407
|
|
G |
ALOX5AP |
arachidonate 5-lipoxygenase activating protein |
|
ISO |
protein:increased expression:nasal turbinate |
RGD |
PMID:19364335 |
RGD:5147461 |
NCBI chr 3:9,618,030...9,642,990
Ensembl chr 3:9,617,949...9,643,184
|
|
G |
CAT |
catalase |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:20493834 |
RGD:5130771 |
NCBI chr 1:30,792,533...30,828,920
Ensembl chr 1:30,792,399...30,829,592
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
protein:increased expression:nasal turbinate, mucosa (human) |
RGD |
PMID:9865755 |
RGD:8548839 |
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
mRNA:increased expression:Nasal Mucosa |
RGD |
PMID:17982926 |
RGD:4145109 |
NCBI chr22:7,795,192...7,801,242
Ensembl chr22:7,798,646...7,799,728
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
mRNA:increased expression:nasal mucosa (human) |
RGD |
PMID:17982926 |
RGD:4145109 |
NCBI chr22:7,803,794...7,818,112
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20226305 |
RGD:5132269 |
NCBI chr 2:17,753,713...17,765,134
Ensembl chr 2:17,753,394...17,764,566
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
protein:increased expression:nasal mucosa, dendritic cell (human) |
RGD |
PMID:17088138 |
RGD:4892343 |
NCBI chr22:58,741,534...58,805,417
Ensembl chr22:58,741,525...58,805,366
|
|
G |
EGR1 |
early growth response 1 |
|
ISO |
DNA:snp:5' utr:g.-4071A>G rs7729723 (human) |
RGD |
PMID:19833116 |
RGD:5131984 |
NCBI chr23:41,139,636...41,143,598
Ensembl chr23:41,140,065...41,142,374
|
|
G |
F2RL1 |
F2R like trypsin receptor 1 |
|
ISO |
|
RGD |
PMID:17727088 |
RGD:4892590 |
NCBI chr 4:71,095,446...71,109,832
Ensembl chr 4:71,095,500...71,110,005
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
susceptibility |
ISO |
DNA:polymorphism:exon:p.I105V (rs1695) (human) |
RGD |
PMID:17181111 |
RGD:4142523 |
NCBI chr 1:6,676,897...6,679,936
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
ISO |
mRNA, protein:increased expression: nasal mucosa |
RGD |
PMID:16540907 |
RGD:4145406 |
NCBI chr19:18,144,466...18,157,944
Ensembl chr19:18,144,545...18,157,971
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased secretion:nasopharynx (human) protein:increased expression:lung, endothelium (mouse) |
RGD |
PMID:19047814 PMID:19968652 |
RGD:4145464 RGD:4145520 |
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
|
|
G |
IFNGR1 |
interferon gamma receptor 1 |
|
ISO |
DNA: SNP: Leu467Pro |
RGD |
PMID:12851715 |
RGD:6480431 |
NCBI chr13:36,203,038...36,224,039
Ensembl chr13:36,203,004...36,222,542
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
mRNA, protein:increased expression:nasal mucosa |
RGD |
PMID:8520776 |
RGD:4782826 |
NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
|
|
G |
IL17A |
interleukin 17A |
severity |
ISO |
protein:increased expression:serum |
RGD |
PMID:19226302 |
RGD:4889151 |
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
|
|
G |
IL18 |
interleukin 18 |
susceptibility |
ISO |
DNA:SNP:promoter:c. -607A>C (rs1946518) (human) |
RGD |
PMID:16406079 |
RGD:4889924 |
NCBI chr 1:103,485,868...103,511,632
Ensembl chr 1:103,482,083...103,510,150
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
DNA:polymorphism:exon:c.4845G>T (human) |
RGD |
PMID:14533660 |
RGD:4142859 |
NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
|
|
G |
IL1R1 |
interleukin 1 receptor type 1 |
|
ISO |
|
RGD |
PMID:18637763 |
RGD:5037238 |
NCBI chr14:5,781,486...5,852,872
Ensembl chr14:5,781,479...5,855,942
|
|
G |
IL2 |
interleukin 2 |
|
ISO |
protein:decreased expression:serum: |
RGD |
PMID:17608155 |
RGD:8662959 |
NCBI chr 7:69,729,635...69,736,279
Ensembl chr 7:69,730,282...69,734,969
|
|
G |
IL4 |
interleukin 4 |
treatment |
ISO |
protein:increased expression:serum |
RGD |
PMID:9237816 PMID:15329007 PMID:21171297 |
RGD:5128559 RGD:7829804 RGD:7829817 |
NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
|
|
G |
IL5 |
interleukin 5 |
|
ISO |
protein: increased levels: sputum |
RGD |
PMID:22186238 |
RGD:5687140 |
NCBI chr23:35,360,143...35,375,169
Ensembl chr23:35,360,506...35,362,178
|
|
G |
LOC103233689 |
thromboxane A2 receptor |
treatment |
ISO |
|
RGD |
PMID:15247523 |
RGD:11059532 |
NCBI chr 6:3,354,358...3,365,779
Ensembl chr 6:3,355,314...3,359,761
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
|
ISO |
protein:increased expression:nasal mucosa: |
RGD |
PMID:19786210 |
RGD:5130872 |
NCBI chr 5:41,264,382...41,291,657
Ensembl chr 5:41,264,354...41,291,004
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:nasal mucosa: |
RGD |
PMID:19786210 |
RGD:5130872 |
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:nasal mucosa |
RGD |
PMID:14587983 |
RGD:4892078 |
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
|
|
G |
NOS3 |
nitric oxide synthase 3 |
|
ISO |
DNA:snp:promoter:g.-786T>C (human) |
RGD |
PMID:18086269 |
RGD:4892054 |
NCBI chr21:119,174,829...119,196,840
|
|
G |
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
|
ISO |
protein:altered expression:nasal mucosa |
RGD |
PMID:20185258 |
RGD:4892593 |
NCBI chr23:45,904,926...46,031,804
Ensembl chr23:45,904,873...46,031,125
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
|
ISO |
mRNA, protein:increased expression:nasal mucosa (human) |
RGD |
PMID:17116814 |
RGD:8552811 |
NCBI chr22:48,262,743...48,407,415
Ensembl chr22:48,275,600...48,407,418
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
protein:increased expression:respiratory system epithelium |
RGD |
PMID:19364335 |
RGD:5147461 |
NCBI chr12:17,195,403...17,218,450
Ensembl chr12:17,192,628...17,218,315
|
|
|
G |
PLAU |
plasminogen activator, urokinase |
|
ISO |
Gene product used in treatment of disease |
RGD |
PMID:20304453 |
RGD:4891955 |
NCBI chr 9:57,452,904...57,459,345
Ensembl chr 9:57,452,761...57,459,286
|
|
G |
TNC |
tenascin C |
|
ISO |
protein:increased expression:pleura |
RGD |
PMID:10950882 |
RGD:4889594 |
NCBI chr12:24,457,616...24,556,194
Ensembl chr12:24,457,738...24,556,451
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
treatment |
ISO |
|
RGD |
PMID:20819512 |
RGD:127284851 |
NCBI chr17:30,873,647...30,885,292
Ensembl chr17:30,873,666...30,886,967
|
|
|
G |
ADA |
adenosine deaminase |
|
ISO |
protein:increased activity:serum: protein:increased expression:serum: protein:increased activity:pleural fluid: |
RGD |
PMID:1689629 PMID:1818842 PMID:18357489 PMID:21860532 |
RGD:152995280 RGD:152995288 RGD:152995292 RGD:152998934 |
NCBI chr 2:19,167,209...19,200,233
|
|
G |
CCL22 |
C-C motif chemokine ligand 22 |
|
ISO |
|
RGD |
PMID:20337996 |
RGD:4891473 |
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:19159432 |
RGD:4145106 |
NCBI chr22:7,795,192...7,801,242
Ensembl chr22:7,798,646...7,799,728
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
protein:increased expression:pleural fluid, natural killer cell (human) |
RGD |
PMID:19159432 |
RGD:4145106 |
NCBI chr22:7,803,794...7,818,112
|
|
G |
FOXP3 |
forkhead box P3 |
disease_progression |
ISO |
associated with human immunodeficiency virus infectious disease; |
RGD |
PMID:21303360 |
RGD:36947878 |
NCBI chr X:46,349,890...46,365,133
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
DNA:polymorphism: :3953T>C (human) |
RGD |
PMID:10377182 |
RGD:4143226 |
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
DNA:repeat (human) |
RGD |
PMID:10377182 |
RGD:4143226 |
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
|
|
G |
IL27 |
interleukin 27 |
exacerbates |
ISO |
associated with Pleural Effusion;protein:increased expression:pleural fluid (human) protein:increased expression:alveolar system (human) |
RGD |
PMID:23962500 PMID:25753767 PMID:28844060 PMID:31819557 |
RGD:126790505 RGD:126790517 RGD:126790523 RGD:126790549 |
NCBI chr 5:26,348,559...26,358,028
Ensembl chr 5:26,348,848...26,356,360
|
|
G |
IL33 |
interleukin 33 |
|
ISO |
protein:increased expression:pleural fluid: |
RGD |
PMID:23301222 |
RGD:39939042 |
NCBI chr12:73,235,585...73,283,665
Ensembl chr12:73,237,406...73,252,436
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:pleura: |
RGD |
PMID:18715875 |
RGD:5129700 |
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
|
|
G |
TLR4 |
toll like receptor 4 |
|
ISO |
|
RGD |
PMID:18295348 |
RGD:4144193 |
NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
|
|
G |
TNC |
tenascin C |
|
ISO |
protein:increased expression:pleura |
RGD |
PMID:10950882 |
RGD:4889594 |
NCBI chr12:24,457,616...24,556,194
Ensembl chr12:24,457,738...24,556,451
|
|
|
G |
ADA |
adenosine deaminase |
|
ISO |
|
RGD |
PMID:16860713 |
RGD:5128847 |
NCBI chr 2:19,167,209...19,200,233
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:9109363 |
RGD:4890429 |
NCBI chr 9:41,085,257...41,145,760
Ensembl chr 9:41,085,361...41,145,331
|
|
G |
ANXA1 |
annexin A1 |
|
ISO |
|
RGD |
PMID:15784654 |
RGD:2306907 |
NCBI chr12:84,207,818...84,226,438
Ensembl chr12:84,207,820...84,226,562
|
|
G |
BDKRB1 |
bradykinin receptor B1 |
|
ISO |
|
RGD |
PMID:11853231 |
RGD:5129218 |
NCBI chr24:74,136,464...74,146,668
Ensembl chr24:74,145,531...74,146,592
|
|
G |
BDKRB2 |
bradykinin receptor B2 |
|
ISO |
|
RGD |
PMID:9208140 PMID:15316088 |
RGD:4891029 RGD:4891041 |
NCBI chr24:74,084,907...74,125,604
Ensembl chr24:74,118,210...74,122,909
|
|
G |
C3 |
complement C3 |
|
ISO |
protein:increased activity:pleural cavity |
RGD |
PMID:18256172 |
RGD:5129520 |
NCBI chr 6:6,250,422...6,289,264
|
|
G |
CAT |
catalase |
|
ISO |
|
RGD |
PMID:19778612 |
RGD:5130749 |
NCBI chr 1:30,792,533...30,828,920
Ensembl chr 1:30,792,399...30,829,592
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
|
ISO |
protein:increased expression:pleural fluid |
RGD |
PMID:11564646 PMID:11877329 |
RGD:4145443 RGD:4145479 |
NCBI chr16:27,792,699...27,796,437
Ensembl chr16:27,794,033...27,796,460
|
|
G |
CCL25 |
C-C motif chemokine ligand 25 |
|
ISO |
protein:increased expression:pleural fluid |
RGD |
PMID:18056919 |
RGD:5130924 |
NCBI chr 6:7,496,463...7,504,637
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:lung (mouse) |
RGD |
PMID:18672096 |
RGD:4890016 |
NCBI chr16:29,351,214...29,361,317
|
|
G |
CCR3 |
C-C motif chemokine receptor 3 |
|
ISO |
associated with Mycobacterium Infections |
RGD |
PMID:17158890 |
RGD:4145643 |
NCBI chr22:7,648,410...7,698,523
Ensembl chr22:7,697,068...7,698,135
|
|
G |
CSF3 |
colony stimulating factor 3 |
|
ISO |
|
RGD |
PMID:8841835 |
RGD:11039424 |
NCBI chr16:66,162,814...66,166,192
Ensembl chr16:66,163,681...66,165,172
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:14527170 |
RGD:5135449 |
NCBI chr 7:22,327,041...22,329,405
Ensembl chr 7:22,569,355...22,569,900 Ensembl chr 7:22,569,355...22,569,900
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
|
RGD |
PMID:14527170 |
RGD:5135449 |
NCBI chr 7:24,526,657...24,529,193
Ensembl chr 7:24,526,680...24,529,130
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
|
RGD |
PMID:14527170 |
RGD:5135449 |
NCBI chr 7:24,507,121...24,513,830
Ensembl chr 7:24,507,130...24,513,121
|
|
G |
EDNRA |
endothelin receptor type A |
|
ISO |
|
RGD |
PMID:15107459 |
RGD:4892325 |
NCBI chr 7:93,980,983...94,043,863
Ensembl chr 7:93,985,797...94,042,296
|
|
G |
ELANE |
elastase, neutrophil expressed |
|
ISO |
|
RGD |
PMID:20860667 |
RGD:10450565 |
NCBI chr 6:599,392...604,925
Ensembl chr 6:601,217...604,725
|
|
G |
ESR1 |
estrogen receptor 1 |
|
ISO |
|
RGD |
PMID:17035596 |
RGD:4892303 |
NCBI chr13:79,153,418...79,554,552
Ensembl chr13:79,270,265...79,554,549
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism associated with Tuberculosis; protein:increased expression:pleural fluid, natural killer cell (human) protein:increased expression:bronchial epithelium (mouse) |
CTD RGD |
PMID:11181422 PMID:19056932 PMID:19714575 |
RGD:4145510 RGD:4145519 |
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
|
|
G |
IL10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11181422 |
|
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
|
RGD |
PMID:10823416 |
RGD:4990464 |
NCBI chr 7:88,548,773...88,644,977
Ensembl chr 7:88,548,671...88,645,488
|
|
G |
IL17A |
interleukin 17A |
treatment |
ISO |
|
RGD |
PMID:21898269 |
RGD:7175307 |
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
protein:increased expression:pleural cavity, exudate (rat) CTD Direct Evidence: marker/mechanism protein:increased expression:lung |
RGD CTD |
PMID:11181422 PMID:20141620 PMID:20175894 PMID:21898269 |
RGD:4142808 RGD:4142826 RGD:7175307 |
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
|
RGD |
PMID:8491511 |
RGD:4143233 |
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11181422 |
|
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
|
|
G |
MPO |
myeloperoxidase |
|
ISO |
protein:increased activity:lung |
RGD |
PMID:11577999 |
RGD:5130991 |
NCBI chr16:35,120,194...35,130,851
Ensembl chr16:35,120,581...35,130,671
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
|
RGD |
PMID:14673141 |
RGD:6893408 |
NCBI chr10:62,789,647...62,825,651
Ensembl chr10:62,790,124...62,825,339
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:pleural cavity (rat) |
RGD |
PMID:20141620 PMID:21898269 |
RGD:4142808 RGD:7175307 |
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
|
|
G |
PLA2G6 |
phospholipase A2 group VI |
|
ISO |
|
RGD |
PMID:15003994 |
RGD:6482741 |
NCBI chr19:20,818,575...20,884,243
|
|
G |
PTAFR |
platelet activating factor receptor |
treatment |
ISO |
|
RGD |
PMID:8395390 |
RGD:10043147 |
NCBI chr20:104,627,591...104,658,840
Ensembl chr20:104,657,179...104,658,207
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:15740981 PMID:20141620 |
RGD:4142808 RGD:5143929 |
NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
|
|
G |
SELP |
selectin P |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:lung |
CTD RGD |
PMID:11181422 PMID:21147071 |
RGD:6219005 |
NCBI chr25:59,420,910...59,465,140
Ensembl chr25:59,433,333...59,462,598
|
|
G |
SERPINE1 |
serpin family E member 1 |
susceptibility |
ISO |
associated with Familial Mediterranean Fever;DNA: DNA:polymorphism:promoter:rs1799768 (human): |
RGD |
PMID:23052617 |
RGD:13207414 |
NCBI chr28:12,047,520...12,060,662
Ensembl chr28:12,047,529...12,060,202
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11161459 PMID:11181422 PMID:20141620 |
RGD:4142808 RGD:4143474 |
|
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:12773506 |
RGD:4890419 |
NCBI chr 9:41,085,257...41,145,760
Ensembl chr 9:41,085,361...41,145,331
|
|
|
G |
AICDA |
activation induced cytidine deaminase |
|
ISO |
|
RGD |
PMID:26456931 |
RGD:11098923 |
NCBI chr11:8,426,920...8,438,331
Ensembl chr11:8,428,922...8,431,641
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:20231413 |
RGD:4890435 |
NCBI chr 9:41,085,257...41,145,760
Ensembl chr 9:41,085,361...41,145,331
|
|
G |
BTK |
Bruton tyrosine kinase |
ameliorates |
ISO |
|
RGD |
PMID:30646846 |
RGD:124715470 |
NCBI chr X:89,690,569...89,727,420
|
|
G |
C3 |
complement C3 |
disease_progression |
ISO |
protein:decreased expression:serum associated with Liver Cirrhosis, Experimental;protein:decreased expression:respiratory system fluid/secretion |
RGD |
PMID:20405 PMID:15972516 PMID:17956621 |
RGD:5129509 RGD:5129523 RGD:5130163 |
NCBI chr 6:6,250,422...6,289,264
|
|
G |
C5 |
complement C5 |
severity |
ISO |
|
RGD |
PMID:7814608 |
RGD:5130159 |
NCBI chr12:18,525,855...18,624,048
Ensembl chr12:18,525,880...18,623,636
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
susceptibility |
ISO |
|
RGD |
PMID:16455992 |
RGD:4892130 |
NCBI chr16:29,351,214...29,361,317
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:17185649 |
RGD:4144788 |
NCBI chr23:43,264,917...43,266,825
Ensembl chr23:43,264,336...43,266,993
|
|
G |
CHI3L1 |
chitinase 3 like 1 |
|
ISO |
protein:increased secretion:serum (human) |
RGD |
PMID:10515841 |
RGD:4892626 |
NCBI chr25:26,160,993...26,169,005
Ensembl chr25:26,160,961...26,169,566
|
|
G |
CRHR2 |
corticotropin releasing hormone receptor 2 |
|
ISO |
|
RGD |
PMID:21774994 |
RGD:5147472 |
NCBI chr21:27,703,637...27,738,873
Ensembl chr21:27,708,113...27,739,116
|
|
G |
CRP |
C-reactive protein |
disease_progression |
ISO |
|
RGD |
PMID:21281676 |
RGD:5131293 |
NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:20958976 |
RGD:5134957 |
NCBI chr 7:22,327,041...22,329,405
Ensembl chr 7:22,569,355...22,569,900 Ensembl chr 7:22,569,355...22,569,900
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr 7:22,202,497...22,205,730
Ensembl chr 7:22,202,527...22,204,068
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:20381636 |
RGD:5135285 |
NCBI chr 7:24,507,121...24,513,830
Ensembl chr 7:24,507,130...24,513,121
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
ISO |
associated with influenza;protein:increased expression:lung |
RGD |
PMID:17348295 |
RGD:4145366 |
NCBI chr19:18,144,466...18,157,944
Ensembl chr19:18,144,545...18,157,971
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
protein:increased expression:alveolar macrophage, bronchial epithelial cell |
RGD |
PMID:17611121 |
RGD:5000755 |
NCBI chr 7:88,548,773...88,644,977
Ensembl chr 7:88,548,671...88,645,488
|
|
G |
IL15RA |
interleukin 15 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:17611121 |
RGD:5000755 |
NCBI chr 9:6,061,475...6,096,370
Ensembl chr 9:6,061,197...6,096,250
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
|
RGD |
PMID:19995896 |
RGD:4888531 |
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:15770015 |
RGD:4889960 |
NCBI chr 1:103,485,868...103,511,632
Ensembl chr 1:103,482,083...103,510,150
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
|
RGD |
PMID:20643849 |
RGD:4143255 |
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
|
|
G |
LEP |
leptin |
|
ISO |
|
RGD |
PMID:17822444 |
RGD:5128869 |
NCBI chr21:97,056,913...97,071,161
Ensembl chr21:97,057,529...97,071,220
|
|
G |
LEPR |
leptin receptor |
|
ISO |
|
RGD |
PMID:21148797 |
RGD:5128846 |
NCBI chr20:67,454,205...67,567,524
Ensembl chr20:67,454,334...67,524,229
|
|
G |
LOC103243260 |
corticotropin-releasing factor receptor 1 |
|
ISO |
|
RGD |
PMID:21774994 |
RGD:5147472 |
NCBI chr16:60,070,156...60,120,857
Ensembl chr16:60,070,066...60,120,712
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr19:4,246,144...4,352,648
Ensembl chr19:4,246,122...4,353,325
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr 5:26,536,471...26,545,666
Ensembl chr 5:26,536,532...26,546,461
|
|
G |
MASP2 |
MBL associated serine protease 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12904520 |
|
NCBI chr20:120,731,591...120,753,104
|
|
G |
MBL2 |
mannose binding lectin 2 |
no_association |
ISO |
DNA:mutations:5' utr, exon:multiple (human) DNA:polymorphisms:5' utr, exon:multiple (human) |
RGD |
PMID:12047967 PMID:18641104 |
RGD:4889477 RGD:4889478 |
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
|
RGD |
PMID:17056580 |
RGD:4891950 |
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
|
|
G |
PTEN |
phosphatase and tensin homolog |
ameliorates |
ISO |
myeloid knockout |
RGD |
PMID:20505137 |
RGD:127285597 |
NCBI chr 9:81,308,058...81,412,386
Ensembl chr 9:81,309,099...81,409,146
|
|
G |
SFTPD |
surfactant protein D |
severity |
ISO |
|
RGD |
PMID:16255775 |
RGD:4143519 |
NCBI chr 9:51,809,241...51,820,974
Ensembl chr 9:51,811,052...51,820,650
|
|
G |
SIRT1 |
sirtuin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr 9:63,463,059...63,497,893
Ensembl chr 9:63,462,389...63,497,867
|
|
G |
STING1 |
stimulator of interferon response cGAMP interactor 1 |
|
ISO |
|
RGD |
PMID:29263110 |
RGD:39128230 |
NCBI chr23:42,153,576...42,160,903
Ensembl chr23:42,153,026...42,160,907
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:19956717 |
RGD:4145321 |
NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
associated with influenza;protein:increased expression:lung |
RGD |
PMID:9032201 PMID:17348295 |
RGD:4143479 RGD:4145366 |
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
ameliorates |
ISO |
|
RGD |
PMID:19596984 PMID:24752755 |
RGD:126928121 RGD:127229903 |
NCBI chr17:30,873,647...30,885,292
Ensembl chr17:30,873,666...30,886,967
|
|
|
G |
AZIN1 |
antizyme inhibitor 1 |
|
ISO |
mRNA:increased expression:alveolar macrophage |
RGD |
PMID:19158080 |
RGD:14700806 |
NCBI chr 8:97,679,775...97,717,486
Ensembl chr 8:97,679,468...97,696,928
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:17169032 |
RGD:5129525 |
NCBI chr 6:6,250,422...6,289,264
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:20618689 |
RGD:4891428 |
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
|
|
G |
CD40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:10968950 |
RGD:8547797 |
NCBI chr 2:17,753,713...17,765,134
Ensembl chr 2:17,753,394...17,764,566
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:19487471 |
RGD:5131475 |
NCBI chr23:34,906,987...34,911,252
Ensembl chr23:34,908,911...34,911,140
|
|
G |
IL23A |
interleukin 23 subunit alpha |
|
ISO |
|
RGD |
PMID:17403873 |
RGD:39458043 |
NCBI chr11:52,289,486...52,296,735
Ensembl chr11:52,295,106...52,297,244
|
|
G |
IL33 |
interleukin 33 |
treatment |
ISO |
|
RGD |
PMID:21220696 |
RGD:40400892 |
NCBI chr12:73,235,585...73,283,665
Ensembl chr12:73,237,406...73,252,436
|
|
G |
MUC1 |
mucin 1, cell surface associated |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9617869 |
RGD:5131424 |
NCBI chr20:8,641,701...8,646,739
Ensembl chr20:8,642,842...8,646,962
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:decreased dimerization:alveolar macrophage mRNA:increased expression:alveolar macrophage |
RGD |
PMID:20377877 PMID:20558778 |
RGD:4144112 RGD:4891486 |
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
|
|
G |
SFTPB |
surfactant protein B |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr14:21,487,424...21,497,491
Ensembl chr14:21,488,387...21,499,850
|
|
G |
SFTPC |
surfactant protein C |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr 8:20,229,756...20,233,568
Ensembl chr 8:20,230,870...20,234,020
|
|
G |
SFTPD |
surfactant protein D |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr 9:51,809,241...51,820,974
Ensembl chr 9:51,811,052...51,820,650
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:18400546 |
RGD:4145341 |
NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
|
|
|
G |
ABO |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
severity |
ISO |
DNA:polymorphism:cds:allele A (human) |
RGD |
PMID:4375858 |
RGD:39938844 |
NCBI chr12:4,863,100...4,892,204
Ensembl chr12:4,863,165...4,885,849
|
|
G |
ADORA1 |
adenosine A1 receptor |
|
ISO |
|
RGD |
PMID:15630442 |
RGD:5129098 |
NCBI chr25:26,180,898...26,221,424
Ensembl chr25:26,182,446...26,220,776
|
|
G |
ADORA2A |
adenosine A2a receptor |
|
ISO |
associated with Anemia, Sickle Cell associated with Lung Injury |
RGD |
PMID:17601796 PMID:18703794 PMID:20798237 |
RGD:4890358 RGD:4890364 RGD:4890376 |
NCBI chr19:7,691,678...7,706,781
Ensembl chr19:7,691,536...7,706,926
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
|
ISO |
|
RGD |
PMID:19925785 |
RGD:4145041 |
NCBI chr23:51,445,920...51,447,942
Ensembl chr23:51,446,154...51,447,401
|
|
G |
AGT |
angiotensinogen |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28960804 |
|
NCBI chr25:67,964,840...67,977,006
Ensembl chr25:67,962,401...67,973,324
|
|
G |
AHR |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23337360 |
|
NCBI chr21:40,778,198...40,826,491
Ensembl chr21:40,778,218...40,826,478
|
|
G |
ALB |
albumin |
disease_progression |
ISO |
|
RGD |
PMID:23286966 |
RGD:11035283 |
NCBI chr 7:21,872,036...21,890,095
Ensembl chr 7:21,876,132...21,891,407
|
|
G |
BDKRB2 |
bradykinin receptor B2 |
|
ISO |
|
RGD |
PMID:15021973 |
RGD:4891030 |
NCBI chr24:74,084,907...74,125,604
Ensembl chr24:74,118,210...74,122,909
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:10886251 |
RGD:5129562 |
NCBI chr 6:6,250,422...6,289,264
|
|
G |
C3AR1 |
complement C3a receptor 1 |
|
ISO |
associated with Respiratory Syncytial Virus Infections |
RGD |
PMID:17079327 |
RGD:5129688 |
NCBI chr11:8,128,192...8,135,517
Ensembl chr11:8,128,620...8,130,062
|
|
G |
C5 |
complement C5 |
|
ISO |
associated with Respiratory Syncytial Virus Infections |
RGD |
PMID:3631740 PMID:17079327 |
RGD:5129688 RGD:5130161 |
NCBI chr12:18,525,855...18,624,048
Ensembl chr12:18,525,880...18,623,636
|
|
G |
CASP1 |
caspase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 1:96,389,697...96,400,610
Ensembl chr 1:96,389,657...96,400,849
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
|
ISO |
mRNA, protein:increased expression:lung, respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10595930 PMID:11290805 PMID:21625544 |
RGD:4145445 RGD:4145450 |
NCBI chr16:27,792,699...27,796,437
Ensembl chr16:27,794,033...27,796,460
|
|
G |
CCL13 |
C-C motif chemokine ligand 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr16:27,864,260...27,867,457
Ensembl chr16:27,865,318...27,867,415
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
|
ISO |
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:15993846 PMID:21625544 |
RGD:2306304 |
NCBI chr 5:43,343,525...43,350,096
Ensembl chr 5:43,346,329...43,348,599
|
|
G |
CCL19 |
C-C motif chemokine ligand 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr12:45,928,212...45,930,897
Ensembl chr12:45,929,071...45,930,904
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:respiratory system fluid/secretion |
CTD RGD |
PMID:19648283 PMID:21625544 |
RGD:4891461 |
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
|
|
G |
CCL20 |
C-C motif chemokine ligand 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr10:113,815,099...113,836,562
Ensembl chr10:113,832,573...113,835,736
|
|
G |
CCL24 |
C-C motif chemokine ligand 24 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr28:10,067,482...10,069,992
Ensembl chr28:10,066,664...10,069,695
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15191918 PMID:21625544 |
RGD:5130985 |
NCBI chr16:27,777,795...27,780,413
|
|
G |
CCL8 |
C-C motif chemokine ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr16:27,821,149...27,823,919
Ensembl chr16:27,821,970...27,823,528
|
|
G |
CCR1 |
C-C motif chemokine receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20870892 PMID:21625544 |
RGD:5688175 |
NCBI chr22:7,634,205...7,641,380
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:14615370 PMID:17284325 PMID:21625544 |
RGD:4145068 RGD:8661704 |
NCBI chr22:7,795,192...7,801,242
Ensembl chr22:7,798,646...7,799,728
|
|
G |
CCR3 |
C-C motif chemokine receptor 3 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19762220 |
RGD:4145622 |
NCBI chr22:7,648,410...7,698,523
Ensembl chr22:7,697,068...7,698,135
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
Idiopathic Pneumonia Syndrome; mRNA:increased expression:lung (mouse) |
RGD |
PMID:15546955 |
RGD:4892103 |
NCBI chr22:7,803,794...7,818,112
|
|
G |
CCR6 |
C-C motif chemokine receptor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr13:94,865,480...94,894,331
Ensembl chr13:94,865,936...94,894,315
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:16394278 |
RGD:5130919 |
NCBI chr16:65,620,632...65,632,394
Ensembl chr16:65,620,665...65,632,984
|
|
G |
CCR9 |
C-C motif chemokine receptor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr22:7,354,139...7,375,280
Ensembl chr22:7,354,489...7,377,676
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
protein:increased expression:multiple |
RGD |
PMID:20302606 |
RGD:4144794 |
NCBI chr23:43,264,917...43,266,825
Ensembl chr23:43,264,336...43,266,993
|
|
G |
CD163 |
CD163 molecule |
|
ISO |
associated with liver disease;protein:increased expression:blood serum (human) |
RGD |
PMID:26339412 |
RGD:11251207 |
NCBI chr11:7,501,562...7,536,332
Ensembl chr11:7,501,150...7,536,295
|
|
G |
CD40LG |
CD40 ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr X:111,655,301...111,667,602
Ensembl chr X:111,655,397...111,666,639
|
|
G |
COQ6 |
coenzyme Q6, monooxygenase |
|
ISO |
ClinVar Annotator: match by term: increased susceptibility to pneumonia |
ClinVar |
|
|
NCBI chr24:51,164,328...51,178,522
Ensembl chr24:51,164,378...51,177,620
|
|
G |
CRHR2 |
corticotropin releasing hormone receptor 2 |
|
ISO |
|
RGD |
PMID:16855006 |
RGD:5130933 |
NCBI chr21:27,703,637...27,738,873
Ensembl chr21:27,708,113...27,739,116
|
|
G |
CRP |
C-reactive protein |
severity disease_progression |
ISO |
|
RGD |
PMID:21258955 PMID:21439658 |
RGD:5131283 RGD:5131291 |
NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11732872 PMID:19633061 |
RGD:4142837 |
NCBI chr23:34,906,987...34,911,252
Ensembl chr23:34,908,911...34,911,140
|
|
G |
CSF3R |
colony stimulating factor 3 receptor |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr20:96,380,798...96,397,745
Ensembl chr20:96,384,222...96,398,618
|
|
G |
CSK |
C-terminal Src kinase |
|
ISO |
|
RGD |
PMID:14975240 |
RGD:5134363 |
NCBI chr26:8,667,657...8,688,850
Ensembl chr26:8,667,655...8,688,824
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
mRNA, protein:increased expression:lung CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20728373 PMID:21625544 |
RGD:5134959 |
NCBI chr 7:22,327,041...22,329,405
Ensembl chr 7:22,569,355...22,569,900 Ensembl chr 7:22,569,355...22,569,900
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
associated with Lupus Erythematosus, Systemic;mRNA:increased expression:lung |
RGD |
PMID:14979941 PMID:15265940 |
RGD:5135445 RGD:5135491 |
NCBI chr 7:24,526,657...24,529,193
Ensembl chr 7:24,526,680...24,529,130
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:21625544 PMID:32407669 |
RGD:30296672 |
NCBI chr 7:22,202,497...22,205,730
Ensembl chr 7:22,202,527...22,204,068
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:15265940 PMID:17052299 PMID:21625544 |
RGD:5135440 RGD:5135445 |
NCBI chr 7:24,507,121...24,513,830
Ensembl chr 7:24,507,130...24,513,121
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
associated with Lupus Erythematosus, Systemic;mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:14979941 PMID:15265940 PMID:21625544 |
RGD:5135445 RGD:5135491 |
NCBI chr X:61,430,723...61,433,777
Ensembl chr X:61,430,725...61,433,386
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:15928955 |
RGD:4142512 |
NCBI chr26:8,753,236...8,759,378
Ensembl chr26:8,753,327...8,759,384
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
|
ISO |
protein:increased expression:alveolus, epithelial cell DNA:polymorphism (human) |
RGD |
PMID:14698565 PMID:15928955 |
RGD:4142512 RGD:4892223 |
NCBI chr26:53,390,054...53,403,309
Ensembl chr26:53,390,089...53,404,211
|
|
G |
DEFB1 |
defensin beta 1 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:17000097 |
RGD:4892262 |
NCBI chr 8:6,643,753...6,652,209
Ensembl chr 8:6,643,556...6,651,699
|
|
G |
EDN1 |
endothelin 1 |
severity |
ISO |
protein:increased secretion:plasma (human) |
RGD |
PMID:20529344 |
RGD:4144879 |
NCBI chr17:59,854,186...59,861,319
Ensembl chr17:59,853,699...59,861,198
|
|
G |
EGF |
epidermal growth factor |
resistance |
ISO |
|
RGD |
PMID:21701422 |
RGD:6906904 |
NCBI chr 7:57,810,110...57,911,361
Ensembl chr 7:57,811,728...57,911,516
|
|
G |
EGR1 |
early growth response 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29787794 |
|
NCBI chr23:41,139,636...41,143,598
Ensembl chr23:41,140,065...41,142,374
|
|
G |
ENTPD5 |
ectonucleoside triphosphate diphosphohydrolase 5 (inactive) |
|
ISO |
ClinVar Annotator: match by term: increased susceptibility to pneumonia |
ClinVar |
|
|
NCBI chr24:51,176,137...51,234,575
Ensembl chr24:51,181,859...51,231,078
|
|
G |
FCGR3A |
Fc fragment of IgG receptor IIIa |
treatment |
ISO |
associated with Hodgkin Disease;DNA:SNP:exon:p.F158V (rs396991) (human) |
RGD |
PMID:20423913 |
RGD:11352258 |
NCBI chr20:2,466,492...2,475,579
|
|
G |
GRP |
gastrin releasing peptide |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:30146822 |
RGD:401700396 |
NCBI chr18:20,496,201...20,508,551
Ensembl chr18:20,496,516...20,507,153
|
|
G |
HDC |
histidine decarboxylase |
|
ISO |
|
RGD |
PMID:14556983 |
RGD:5143922 |
NCBI chr26:33,051,048...33,074,872
Ensembl chr26:33,051,966...33,074,563
|
|
G |
HMOX1 |
heme oxygenase 1 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:allele:promoter:L allele of the (GT)n repeat (>30 repeats) |
CTD RGD |
PMID:16582079 |
RGD:1601608 |
NCBI chr19:18,144,466...18,157,944
Ensembl chr19:18,144,545...18,157,971
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
associated with Reperfusion Injury |
RGD |
PMID:22882462 |
RGD:8547727 |
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
|
|
G |
IFNAR1 |
interferon alpha and beta receptor subunit 1 |
resistance |
ISO |
Cryptococcus (yeast) pneumonia |
RGD |
PMID:18566423 |
RGD:5490275 |
NCBI chr 2:58,824,600...58,854,519
Ensembl chr 2:58,825,916...58,854,568
|
|
G |
IFNG |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
|
|
G |
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20080200 PMID:31095431 |
RGD:7495767 |
NCBI chr 8:40,267,532...40,325,282
Ensembl chr 8:40,268,079...40,326,381
|
|
G |
IL10 |
interleukin 10 |
disease_progression |
ISO |
protein:increased expression:blood |
RGD |
PMID:20595152 |
RGD:4140400 |
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
associated with Respiratory Distress Syndrome, Newborn; protein:increased expression:bronchoalveolar lavage fluid CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19695190 PMID:21625544 |
RGD:4145774 |
NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
|
|
G |
IL13RA2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
mRNA:increased expression:lung, fibroblast |
RGD |
PMID:15161635 |
RGD:4890021 |
NCBI chr X:102,589,947...102,628,853
Ensembl chr X:102,590,045...102,603,260
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20498020 PMID:21625544 PMID:22848348 |
RGD:4888524 RGD:9068417 |
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
mRNA, protein:increased expression:lung,bronchoalveolar fluid CTD Direct Evidence: marker/mechanism associated with reperfusion injury protein:increased expression:serum |
RGD CTD |
PMID:11739527 PMID:15955140 PMID:16052682 PMID:17400729 PMID:21625544 |
RGD:4889590 RGD:4889825 RGD:4889836 RGD:729357 |
NCBI chr 1:103,485,868...103,511,632
Ensembl chr 1:103,482,083...103,510,150
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:8806881 |
RGD:7794765 |
NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
protein:increased expression:lung mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism mRNA:increased expression:bronchoalveolar lavage (human) mRNA, protein:increased expression:lung |
RGD CTD |
PMID:19825784 PMID:19901996 PMID:20007584 PMID:20155581 PMID:20476872 PMID:21625544 PMID:32407669 More...
|
RGD:30296672 RGD:4142536 RGD:4142812 RGD:4142827 RGD:4142831 RGD:4143211 |
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
|
|
G |
IL1R1 |
interleukin 1 receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr14:5,781,486...5,852,872
Ensembl chr14:5,781,479...5,855,942
|
|
G |
IL1R2 |
interleukin 1 receptor type 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:bronchoalveolar lavage (human) |
CTD RGD |
PMID:21625544 PMID:32407669 |
RGD:30296672 |
NCBI chr14:5,672,434...5,708,270
Ensembl chr14:5,673,163...5,708,372
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
disease_progression no_association |
ISO |
DNA:polymorphism:intron (human) DNA:polymorphism (human) mRNA:increased expression:bronchioalveolar lavage fluid, neutrophil (rat) mRNA:increased expression:lung mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:1385928 PMID:16369129 PMID:17569781 PMID:18838927 PMID:19900796 PMID:32407669 More...
|
RGD:30296672 RGD:4142865 RGD:4142871 RGD:4143204 RGD:4143213 RGD:8551846 |
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
|
|
G |
IL27 |
interleukin 27 |
|
ISO |
|
RGD |
PMID:19124731 |
RGD:5128483 |
NCBI chr 5:26,348,559...26,358,028
Ensembl chr 5:26,348,848...26,356,360
|
|
G |
IL2RB |
interleukin 2 receptor subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr19:19,830,919...19,853,534
Ensembl chr19:19,828,898...19,852,988
|
|
G |
IL33 |
interleukin 33 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24453940 |
|
NCBI chr12:73,235,585...73,283,665
Ensembl chr12:73,237,406...73,252,436
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:bronchoalveolar lavage (human) |
CTD RGD |
PMID:21625544 PMID:32407669 |
RGD:30296672 |
NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
|
|
G |
IL4R |
interleukin 4 receptor |
|
ISO |
mRNA:decreased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 5:25,019,638...25,069,732
Ensembl chr 5:25,046,701...25,070,015
|
|
G |
IL5RA |
interleukin 5 receptor subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr22:39,156,711...39,199,394
Ensembl chr22:39,158,023...39,192,861
|
|
G |
IL6 |
interleukin 6 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:blood |
CTD RGD |
PMID:20595152 PMID:21625544 |
RGD:4140400 |
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
|
|
G |
IL6ST |
interleukin 6 cytokine family signal transducer |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 4:52,174,893...52,232,475
Ensembl chr 4:52,174,312...52,214,584
|
|
G |
IRF5 |
interferon regulatory factor 5 |
severity |
ISO |
|
RGD |
PMID:29847542 |
RGD:40907064 |
NCBI chr21:97,536,803...97,549,576
Ensembl chr21:97,537,790...97,549,945
|
|
G |
ITGA2 |
integrin subunit alpha 2 |
treatment |
ISO |
|
RGD |
PMID:11207307 |
RGD:8693217 |
NCBI chr 4:49,280,289...49,382,101
Ensembl chr 4:49,317,648...49,380,051
|
|
G |
ITGA4 |
integrin subunit alpha 4 |
treatment |
ISO |
|
RGD |
PMID:8703473 |
RGD:9698424 |
NCBI chr10:66,984,687...67,063,158
Ensembl chr10:66,984,887...67,061,636
|
|
G |
ITGB2 |
integrin subunit beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10030843 PMID:21625544 |
RGD:6482228 |
NCBI chr 2:88,597,554...88,644,890
Ensembl chr 2:88,597,556...88,624,025
|
|
G |
ITGB3 |
integrin subunit beta 3 |
disease_progression |
ISO |
|
RGD |
PMID:12746502 |
RGD:5100478 |
NCBI chr16:59,372,171...59,431,434
Ensembl chr16:59,374,889...59,410,857
|
|
G |
LCN2 |
lipocalin 2 |
exacerbates |
ISO |
associated with Escherichia Coli Infections |
RGD |
PMID:20633248 |
RGD:126779583 |
NCBI chr12:9,976,278...9,981,087
Ensembl chr12:9,976,614...9,980,870
|
|
G |
LIAS |
lipoic acid synthetase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:32017981 |
|
NCBI chr27:10,832,384...10,850,517
Ensembl chr27:10,829,865...10,850,552
|
|
G |
LOC103217855 |
C-X-C chemokine receptor type 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr10:104,012,906...104,025,599
Ensembl chr10:104,022,811...104,023,893
|
|
G |
LOC103221832 |
ATP-binding cassette sub-family F member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr17:41,866,152...41,885,673
Ensembl chr17:41,866,062...41,884,972
|
|
G |
LOC103233057 |
C-C motif chemokine 22 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:15993846 |
RGD:2306304 |
NCBI chr 5:43,297,206...43,305,662
Ensembl chr 5:43,297,897...43,305,642
|
|
G |
LOC103233058 |
fractalkine |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 5:43,310,711...43,323,533
Ensembl chr 5:43,310,753...43,323,529
|
|
G |
LOC103242767 |
C-C motif chemokine 3 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr16:29,887,799...29,897,664
Ensembl chr16:29,887,883...29,897,544
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
ISO |
protein:increased expression:Bronchoalveolar lavage: protein:increased secretion:lung (human) |
RGD |
PMID:15249448 PMID:18988662 |
RGD:4889459 RGD:8693755 |
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
|
|
G |
MIF |
macrophage migration inhibitory factor |
severity |
ISO |
DNA:repeats:promoter |
RGD |
PMID:19346297 |
RGD:4891058 |
NCBI chr19:7,000,837...7,001,700
Ensembl chr19:7,000,793...7,001,757
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
|
RGD |
PMID:18007984 |
RGD:5130157 |
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
|
|
G |
MUC1 |
mucin 1, cell surface associated |
|
ISO |
protein:increased express | |